2016 Outcomes Report

2016

C.E. Tate TAVR patient Story on page 11

By recruiting some of the world’s most promising clinical trials and putting advanced technologies in the hands of skilled cardiovascular specialists on the medical staff, we are advancing the practice and science of heart and vascular care every day.

Table of Contents 2 3 4 6 8 12 14 16

Welcome Letter Honors Overview THHBP Expansion Top 10 Developments Christmas Island Heart Team Collaboration Valve Surgery 19 TAVR 22 TMVR

24 Robotics 26 Vascular Surgery 28 Thoracic and Abdominal Aortic Disease

31 Electrophysiology 34 Cardiac Catheterization

36 42 44 46

CACC & Diagnostic Imaging Education & Training Women in Heart Disease The Heart Hospital Baylor Denton* 49 Press Ganey ÂŽ 51 Comprehensive Wound & Vascular Center

52 58 59 66 70 79 80 81

Research Board of Managers Physician Partners Medical Staff Publications Data Sources/Appendix Helpful Telephone Numbers Patient Spotlight

*Notice Regarding Physician Ownership: The Heart Hospital Baylor Denton and The Heart Hospital Baylor Plano are hospitals in which physicians have an ownership or investment interest.

The list of the physician owners or investors is available to you upon request.

Welcome Innovation and quality are the foundation of The Heart Hospital Baylor Plano and The Heart Hospital Baylor Denton. Physicians, nurses, researchers and hundreds more representing numerous disciplines build on this foundation daily, each bringing their best to advance the care each guest receives. Every thought, every action, every surgery or procedure relates back to this foundation, which is why Innovation and Quality is the theme of our 2016 Outcomes Report.

Since opening The Heart Hospital Baylor Plano in 2007, our outcomes year after year reinforce that we are a leader and an innovator in the cardiovascular arena. As illustrated on the next page, the honors and accolades we have earned in the past two years alone prove we place our guests first and confirm the high-quality results we produce. This recognition also acts as a testament to the zeal with which we pursue medical excellence and the compassionate and dedicated way it is delivered.

2

You can review our 2015 data in this report for both The Heart Hospital Baylor Plano and The Heart Hospital Baylor Denton, and read our “Top 10” list of innovative medical initiatives. You’ll also learn about our Heart Team approach – a fundamental and critical aspect of our patient care – and you’ll meet former guests whose stories support our unwavering commitment to medical quality and service excellence.

As a top 10 national cardiovascular program, we will strive to continue providing medical intelligence at every level, at every turn, across the spectrum of specialties and services we offer our guests. Our “Cardiac IQ” – based on Innovation and Quality – will increase because of the medical leadership we have in place now and through those who join us in the future, as we redefine the conversation about cardiovascular medicine.

Mark A. Valentine President The Heart Hospital Baylor Plano The Heart Hospital Baylor Denton

David L. Brown, MD President of Medical Affairs

H 2015/2016 HONORS

5%

1%

CABG AVR AVR + CABG

STS NationalDatabase Database

TMTM

Participant 2016 Participant

3-STAR 3-STARRATING RATINGFOR FORTWO 2 CONSECUTIVE CONSECUTIVEYEARS YEARS FROM FROMTHE THESOCIETY SOCIETYOF OF THORACIC THORACICSURGEONS, SURGEONS, PLACING PLACINGUS USIN INTOP TOP1% 1% OF OF1,017 1,013CARDIAC CARDIAC SURGERY SURGERYPROGRAMS PROGRAMS

Five-star rating* for “Overall Patients’ Experiences” by Centers for Medicare & Medicaid Services (CMS)

OF OFHOSPITALS HOSPITALSIN INTHE THEU.S. U.S. EARNED EARNED55STARS STARS

168 HOSPITALS HOSPITALSIN INTHE THEU.S. U.S. EARNED EARNED55STARS STARS

2.8%

18

th

IN INTHE THENATION NATIONFOR FOR CARDIOLOGY CARDIOLOGYAND AND HEART HEARTSURGERY SURGERY

Five-star Five-starrating* rating*for for“Overall “Overall Hospital HospitalQuality” Quality”by byCenters Centers for forMedicare Medicare&&Medicaid Medicaid Services Services(CMS) (CMS)

OF OFHOSPITALS HOSPITALSIN INTHE THEU.S. U.S. EARNED EARNED55STARS STARS

3,544 TOTAL HOSPITALS AND HEALTH CARE FACILITIES RATED RATED HEALTHCARE FACILITIES

1 13 11OF OFONLY ONLY13 13HOSPITALS HOSPITALSIN IN TEXAS TEXASWHO WHOEARNED EARNED55STARS STARS

1 102 11OF OFONLY ONLY102 102HOSPITALS HOSPITALSIN IN THE THENATION NATIONWHO WHOEARNED EARNED 55STARS STARSOUT OUTOF OF3,662 3,662RATED RATED

*Ratings based on CMS reporting. All ratings are updated quarterly. Visit www.medicare.gov/hospitalcompare for latest ratings and full reporting details for each rating category represented.

3

O 2015 Overview

4

25,604

4,427

116

PATIENT VISITS

ADMISSIONS

BEDS

3,894

SURGICAL PROCEDURES PERFORMED IN 2015 (CY)

1,562

1,037

250

CARDIAC

VASCULAR

THORACIC

237

383

425

THORACIC AORTIC

MINIMAL ACCESS/ CARDIAC

OTHER

8,641 4,753 INTERVENTIONAL AND NON-INTERVENTIONAL CATH LAB PROCEDURES

NON-SURGICAL PROCEDURES PERFORMED IN 2015 (CY)

584

732

2,572

VASCULAR INTERVENTIONS

PERIPHERAL CATHETERIZATIONS

ELECTROPHYSIOLOGY PROCEDURES

2,680

DIAGNOSTIC INTERVENTIONS

53

CAROTID INTERVENTIONS

531

PERIPHERAL INTERVENTIONS

980

EP ABLATIONS

1,856

PERCUTANEOUS INTERVENTIONS

531

VASCULAR INTERVENTIONS

201

PERIPHERAL DIAGNOSTIC

430

ABLATIONS FOR AFIB

489

IMPLANTABLE CARDIOVERTERDEFIBRILLATORS

673

PACEMAKERS

217

OTHER

5

Increasing the Capacity for Quality

The Heart Hospital Baylor Plano (THHBP) has embarked upon a $100 million expansion to enhance its ability to bring innovative, quality care to the communities THHBP serves, as well as guests from across the country and around the globe. The centerpiece of the project is a five-story patient tower, with amenities and technologies aimed at improving both the guest and provider experience.

In with the New… THHBP’s expansion, the fifth over the past nine years, will build upon the hospital’s already considerable care and training resources: •

Visionary Design Enhanced main entries, a lush landscape and an expanded lobby with a fireplace will create a warm, inviting environment for guests and their families. Every corner, contour and design element is geared to evoke a sense of calm while flowing seamlessly with the existing facility, resetting expectations of what a hospital experience can and should be.

Three new operating suites

28 additional ambulatory surgery beds with the ability to expand to an additional 28 beds in the future

•

6

•

New 200-seat auditorium

•

New and larger cardiac rehabilitation center

•

Restaurant-style dining facilities

•

Renovated and expanded atrium-style main lobby

•

Dedicated suite for cardiovascular research

Architectural renderings of the expansion convey the new front entrance, plus the additional wing that will house expanded services and capacity.

7

10

Top 10 Developments in Innovation 2015/2016

The Heart Hospital Baylor Plano is committed to advancing the programs, tools and techniques to further the practice and science of cardiovascular medicine.

1 Cardiac and Thoracic Robotic Surgery

Robotic surgery has become the mainstay of both mitral valve and thoracic surgery at The Heart Hospital Baylor Plano. With sophisticated robotic technology in the hands of skilled surgeons, minimally invasive procedures become even less invasive, often resulting in next-day discharge. In fact, we are one of the leading facilities in the country for length-of-stay and outcomes for many robotic procedures.*

2 PARTNER III (Transcatheter Aortic Valve Replacement) Over the past decade, transcatheter aortic valve replacement (TAVR) has been shown to be superior to medical therapy and equally as effective as surgery in high and intermediate risk patients with aortic stenosis. We are one of the nation’s leading enrollers in new pivotal research trials comparing the effectiveness of TAVR to surgery in low-risk patients.

8

*Compared to national data from The Society of Thoracic Surgeons and National Inpatient Sample.

3 Advanced Cardiovascular Imaging

To perform complex structural heart therapies, expertise plus advanced imaging technology and software programs are critical. Using 4-D CT scans from our high-speed CT scanner, 3-D TEE, cardiac MRI and coronary MRA, sophisticated imaging brings exciting new capabilities to both our medical staff and research programs. These services are critical for diagnosing cardiovascular disease and procedure planning.

4 Regional Acute Aortic Syndrome Program

The treatment of acute aortic syndromes such as aortic dissections is best handled by physicians focused on aortic disease management. Our Thoracic Aortic Disease Center has established a regional network and protocols to expedite the transfer of patients with life-threatening aortic conditions to our facility and experienced physicians on the medical staff.

5 Noninvasive Coronary Artery Disease Imaging

Virtual fractional flow reserve studies using a coronary CT scan may represent a future disruptive technology that could lead to a decrease in nuclear heart scans and invasive coronary angiographies that yield normal results. This software-based technology represents a new, noninvasive way to determine the clinical and hemodynamic significance of a coronary blockage using complex computations and flow dynamic calculations.

Due to exceptional outcomes and a high number of robotic thoracic procedures, we have been designated as a da Vinci ÂŽ Robotic Epicenter, a site where surgeons can observe thoracic procedures.

9

10

Top 10 Developments in Innovation 2015/2016

6 Transcatheter Mitral Valve Replacement

Embolization of calcium to the brain is a significant complication of both TAVR and surgical valve replacement. In an effort to make both procedures safer, we are investigating new technologies and techniques to either capture or deflect calcium particles from traveling to the brain during these procedures to mitigate this potential complication.

9 Pulmonary Embolism Response Team (PERT)

Transcatheter aortic valve replacement has changed the management of patients with aortic stenosis through advanced, minimally invasive technology. A similar catheter-based therapy, transcatheter mitral valve replacement (TMVR), could be used to revolutionize the treatment of severe mitral regurgitation. We are leading two national feasibility trials, including performing the first TMVR in the United States.

Sub-massive and massive pulmonary embolisms have a high mortality rate, making identification and early intervention critical.

We are the first hospital in North Texas to develop a multidisciplinary pulmonary embolism response team and formal program to address this serious condition. The physician team on the medical staff makes the critical decision of implementing either catheter-directed therapy, IV-directed therapy or surgical therapy to address pulmonary embolisms and provide our guests with accurate, rapid and quality care.

7 Mitral Annular Calcification – National Trial

10 Structural Heart Fellowship

Mitral annular calcification (MAC), which causes advanced degrees of mitral stenosis and mitral regurgitation, is a highly morbid condition that also presents significant surgical challenges. As an alternative, researchers on our medical staff are leading a national trial investigating the feasibility of placing a valve used for TAVR to address MAC under direct vision through minimally invasive incisions.

10

8 Neuroprotection During Valve Replacement

Despite all the breakthroughs in technology and techniques to treat complex structural heart disease, advanced training at centers across the United States is still lacking. To bolster training efforts of new cardiologists and cardiovascular surgeons in these strategies, we have begun a fellowship training program for both cardiologists and cardiovascular surgeons in the true “Heart Team� approach to patient care.

C.E. Tate Sulphur, OK

Former Guest, The Heart Hospital Baylor Plano

C.E. Tate (“Tinker” to his friends) is an 87-year-old who loves horses and country-western dancing, but he wasn’t fit for either when he started having breathing problems. At The Heart Hospital Baylor Plano, he had a transcatheter aortic valve replacement (TAVR). “I couldn’t walk 100 feet before the procedure. The day after, I could walk around the hospital,” he says. In fact, he felt so well at his follow-up appointment that he danced the Cotton-Eyed Joe. “I still go dancing every week,” he says.

“After having TAVR, I danced at my next checkup.”

11

Christmas Island Taking on Rheumatic Heart Disease in Kiritimati 12

Rheumatic heart disease continues to be a significant health issue worldwide – primarily in poor, developing nations. This is particularly true on the small island of Kiritimati (Christmas Island), one of the 33 islands of the Republic of Kiribati located in the Central Pacific Ocean. Some of these patients will develop progressive deterioration of the mitral and aortic valves and require open heart surgery in order to prevent premature death from congestive heart failure.

The Heart Hospital Baylor Plano (THHBP) established a relationship with a nonprofit organization, Pacific Islands Medical Aid, Inc., in 2009 in an effort to provide surgical care for these patients from Kiritimati [kuh-rismuhs]. Since that time, three groups of patients have traveled to THHBP for surgery; the first in 2009 and a second group in 2011. Our medical team has recently returned from the island where more than 300 patients were screened for rheumatic heart disease. As a result of this trip, a third group came to Plano in July 2016 for surgery.

Baylor Scott & White Health has demonstrated strong support for humanitarian efforts to provide care for those without resources. This initiative will be expanded in the coming year to include the larger, more populous island of Tarawa.

The Chain of Hope Foundation, established by worldrenowned heart surgeon Sir Madgi Yacoub, will soon collaborate with THHBP to provide cardiovascular surgical care for a number of patients from Haiti and Central America. All of this is possible due to the commitment of the hospital, surgeons and staff who will care for them. This is an exciting time for THHBP as it expands our mission of providing excellent cardiovascular care on a global level.

Captain William Mynors, of the British East India Company ship Royal Mary, gave the island its name because he and his crew arrived on Christmas Day in 1643.

2016

300 ISLANDERS SCREENED

Left to right: Michael Rampoldi, RDCS, RVT, FASE Supervisor of Ultrasound, Technical Director

David O. Moore, MD

Medical Director, Physician Champion in Patient Safety, THHBP

Dr. Moore and Michael Rampoldi traveled to Kiritimati this year to perform the necessary screenings.

8 SURGERIES*

32 SURGERIES SINCE 2009 *7 performed at THHBP.

13

Heart Team

Collaboration

Left to right:

14

Front Row: Michael DiMaio, MD, Medical Director, Residency/Fellowship Program; David L. Brown, MD, President of Medical Affairs; Deepika Gopal, MD, Medical Director, Advanced Cardiovascular Imaging MRI Program; Molly Szerlip, MD, Medical Director, Inpatient Valve Services; Michael J. Mack, MD, Medical Director, Baylor Scott & White Health Cardiovascular Services; William H. Ryan III, MD, Chairman, Cardiovascular Surgical Services. Back Row: William T. Brinkman, MD, Medical Director, CACC/Thoracic Aortic Disease Center; Robert L. Smith II, MD, Vice Chair, Cardiovascular Surgical Services; Kelley A. Hutcheson, MD; Ambarish Gopal, MD, Medical Director, Advanced Cardiovascular Imaging CT Program; Srini P. Potluri, MD, Medical Director, Cardiac Catheterization Laboratory; Katherine B. Harrington, MD; Steven Kindsvater, MD, Vice Chairman, Cardiovascular Medicine

Teaming with Quality While advanced technologies and skilled providers are vital to creating quality results, the cornerstone of quality at The Heart Hospital Baylor Plano (THHBP) is a team approach to addressing complex cardiovascular conditions, taken to a level that few other programs in the nation can match. THHBP’s program structure gives guests with complicated issues input from multiple specialists on the medical staff, often in a single clinic visit.

P E RM AN Eweekly N T C VA 2 01 5 THHBP’s valve clinics are perhaps the best illustration of theTHeart HHBPTeam approach to care. At the clinics, guests receive a 2.4% fullSevaluation and imaging studies, and have their cases reviewed 2.2% TS 1.9% by multiple specialists on the medical staff, including cardiovascular 1.3% 1.3% surgeons, interventional cardiologists, noninvasive cardiologists and 0.5% cardiac imaging specialists. Thus, every case is looked 0% 0% at through multiple lenses to determine a comprehensive treatment Isolated plan.Isolated AVR plus Isolated CABG

AVR

CABG

Isolated CABG Mortality

THHBP STS 1.3%

2.4%

2.2%

1.9%

1.3%

0.5% 0%

Isolated CABG

Isolated AVR

0%

AVR plus CABG

Isolated MVR

OPERATIVE MORTALITY 2015 THHBP STS

T HHBP STS 0.7%

PERMANENT CVA 2015

MVR

OPE RAT IVE MORTA LITY 20 15

2.2%

This team approach also extends to other areas of cardiovascular medicine. The close working relationship among interventional cardiologists, cardiovascular surgeons and electrophysiologists on the medical staff helps promote the right treatment plan for guests with other complex diseases of the heart.

4.7%

3.9%

0.6% 2.1%

1.7%

Isolated AVR Mortality

AVR plus CABG Mortality

0%

Isolated MVR

0.7% 0.9% 1.1%

2.2%

Isolated IsolatedCABG Mortality MV Repair

4.7%

3.9%

0.6% 2.1%

1.7%

Isolated AVR Mortality

AVR plus CABG Mortality

0%

Isolated MVR

0.9% 1.1%

Isolated MV Repair

15

CV

Increasingly, minimally invasive techniques are accounting for a greater share of procedures in both THHBP’s mitral and aortic valve surgery programs, helping contribute to low complication rates. These include MitraClip® for mitral valve repair, as well as minimal access aortic valve surgery. Compared to The Society of Thoracic Surgeons’ database, THHBP operative mortality rates across the four major areas of valve surgery remained well below average, including:

Valve Surgery

Key Complication Rates Significantly Below National Averages

•

Isolated aortic valve replacement (AVR)

•

AVR with coronary artery bypass graft

•

Isolated mitral valve replacement (MVR)

•

Isolated mitral valve repair

In 2015, The Heart Hospital Baylor Plano’s (THHBP) Valve Program performed more than 1,000 procedures for the first time in the hospital’s history. By caseload, THHBP is one of the nation’s busiest centers for valve surgery.

841 V A LV E S U R G E R Y

682

T O TA L S P E R Y E A R APPROACHING 10 YEARS

587

TAVR VALV E + VALVE MV R AV R

340

200

53

423

487

102 180

165

48

222

234

408

408

116 213 168 176

162

120

97 246

190

218

151

134

99

77

57

34 68

1,025

961

248

392

350

312

98

2007

16

2008

2009

2010

2011

2012

2013

2014

2015

Star Swaner Wylie, TX

Former Guest, The Heart Hospital Baylor Plano

After a life of near perfect health, Star Swaner suddenly found herself in the ER with a strep infection, pneumonia and shortness of breath.

Tests revealed that both her aortic valve and mitral valve were damaged. At The Heart Hospital Baylor Plano, she underwent surgery to repair her mitral valve and replace her aortic valve. Now, even though she was active and felt healthy before, things are different. “I feel healthier than I ever have,” she says. “I could not have been in better hands.”

“After valve surgery, my heart has never felt stronger.”

17

I S O L AT E D A V R M O R TA L I T Y P E R C E N TA G E P E R Y E A R

1.6% 2012

3.6% 2013

A O R T I C V A LV E S U R G E R Y

578

23% Minimal Access

701 218

151

31.7% Minimal Access

510

476 77.3% Traditional

72.7% Traditional

2012

18

2015

22.7% Minimal Access

27.3% Minimal Access

423 77% Traditional

2014

102

471 48

0.6%

661

T O TA L S P E R Y E A R

TAV R AORT IC SU R G E RY

1.3%

2013

483 68.3% Traditional

2014

2015

Valve Surgery

Transcatheter Aortic Valve Replacement (TAVR)

TAVR Has Been Shown to Be the Preferred Treatment for High Surgical Risk Patients with Aortic Valve Stenosis.

This is one of the reasons THHBP has remained at the forefront in developing a robust TAVR program. The number of TAVR cases at THHBP has increased more than four-fold since the launch of the program in 2012. TAVR accounts for an increasing share of aortic valve replacement procedures, and THHBP has one of the nation’s most active and experienced TAVR programs: Lengths of stay for guests who undergo TAVR continue to decrease, with a significant number going home the day after surgery, compared to five to seven days with traditional aortic valve replacement surgery •

The TAVR procedure time, in some cases, is only 25–35 minutes per case. Shorter procedures may offer fewer chances for complications and help speed recovery

•

R E S E A R C H

T R I A L S

PA R T N E R I I I Principal Investigators: David L. Brown, MD/Michael Mack, MD Establish the safety and effectiveness of the SAPIEN 3 Transcatheter Heart Valve in low-risk patients requiring aortic valve replacement who have severe, calcific, symptomatic aortic stenosis.

GALILEO Principal Investigator: Molly Szerlip, MD Global study comparing a rivaroxaban-based antithrombotic strategy to an antiplatelet-based strategy after transcatheter aortic valve replacement (TAVR) to optimize clinical outcomes.

19

Valve Surgery

Transcatheter Aortic Valve Replacement (TAVR)

218

TA V R T O TA L S P E R Y E A R

151 Advancing TAVR

102

THHBP is among only a handful of centers in the United States studying the use of TAVR in low-risk patients with critical aortic stenosis. Since 2002, more than 250,000 TAVR procedures have been performed worldwide – first in patients who were inoperable, then those at high risk for surgery and now for those at intermediate risk. Exploring the use of TAVR in low-risk patients could usher in a new standard of care for any patient in need of aortic valve replacement, further diminishing the need for and risk of surgery.

48

2012

R E S E A R C H

2013

2014

2015

T R I A L

REFLECT I (EMBOLIC PROTECTION) Principal Investigator: David L. Brown, MD This study is a prospective, single-blind, randomized trial in the United States, Europe and Israel. Subjects with indications for TAVR will be randomized 2:1 to one of two treatment arms:

•

Intervention: TAVR with the TriGuard HDH embolic deflection device

•

Control: standard unprotected TAVR

All subjects will be followed in-hospital and at 30 and 90 days with MRI and neuropsychological testing.

20

Edith Geske Chandler, TX

Former Guest, The Heart Hospital Baylor Plano

As a young woman, Edith Geske survived rheumatic fever, but it left her with a heart murmur. More than six decades later, her aortic valve was damaged beyond repair. Her doctor sent her to The Heart Hospital Baylor Plano, where she received a transcatheter aortic valve replacement (TAVR), a no-incision procedure. “That was the best hospital I have ever been in, and at my age, I’ve been in a lot,” the 95-year-old says. Now she’s back to her active, independent life. “I’m back to normal,” she says. “I feel just wonderful.”

“I got a new heart valve and went home the next day.”

21

Valve Surgery

Transcatheter Mitral Valve Replacement (TMVR)

In 2015, THHBP Was the First Institution to Successfully Perform TMVR in the United States.

Due to the complexity of the mitral valve, device development has taken longer than for the aortic valve. However, THHBP is involved in trials for investigative devices that represent the first significant efforts to perform TMVR in the United States, and these efforts could lead to game-changing procedures for mitral valve disease that may expand treatment options and hasten recovery.

These devices represent the first wave of technologies that could shift the paradigm for treating mitral valve disease.

The medical device industry continues to look to THHBP to conduct important trials to determine the efficacy of these novel devices.

22

Advancing TMVR Over the next decade, additional devices will be developed to treat complex cases of mitral valve disease and speed recovery of patients. Currently, THHBP is participating in multiple trials with such devices with success, including no operative mortalities.

R E S E A R C H

T R I A L S

CARDIAQ – FORTIS Principal Investigators: Robert L. Smith II, MD/Molly Szerlip, MD Early feasibility study of the CardiAQ™ Transcatheter Mitral Valve Implantation (TMVI) System (Transfemoral and Transapical Delivery Systems) for the treatment of moderate to severe mitral regurgitation.

SITRAL Principal Investigator: Robert L. Smith II, MD The purpose of this study is to establish the safety and feasibility of the Edwards SAPIEN 3 valve in subjects with mitral annular calcification (MAC) associated with mitral stenosis (MS) and/or mitral regurgitation who are at high risk for mitral valve surgery due to the extent of calcification. The study will include subjects undergoing mitral valve replacement with the Edwards SAPIEN 3 heart valve by a surgical approach. Subjects will undergo follow-up visits at 30 days, 6 months and 12 months post-procedure.

369

M I T R A L V A LV E T O TA L S P E R Y E A R

6

330

T MVR MI T R AL C LI P MI T R AL SU R GE RY

7.2% Robotic

3 13

10.7% Robotic

8.8% Robotic

267

363

46.8% Minimal Invasive

2.3% Robotic

45.7% Minimal Invasive

37.4% Minimal Invasive

55.6% Minimal Invasive 363

347

330 267

60.3% Traditional

45.5% Traditional

46% Traditional 33.7% Traditional

2012

2013

2014

2015

23

CV Robotics

One of the Region’s Most Experienced Programs with Results to Match

The Heart Hospital Baylor Plano (THHBP) is home to one of Texas’ busiest robotic cardiothoracic surgery programs.

Robotic-assisted surgery is among the hospital’s most important minimally invasive solutions in both thoracic procedures and select cardiac interventions.

Cardiac Robotic Surgery THHBP has used robotics to aid in a number of cardiac procedures since the inception of the program in 2011. Thanks in part to robotic techniques, THHBP’s operative mortality rate for mitral valve procedures has remained well below national averages. In addition, lengths of stay continue to decrease for guests who undergo robotic mitral valve procedures.

In addition to mitral valve procedures, cardiac robotics at THHBP can also be used to treat adult congenital heart conditions such as atrial septal defect (ASD), and to assist in complex bypass surgeries.

ROBOTIC SURGERY T O TA L S P E R Y E A R

ASD/TUMOR RESECTION MITRAL VALV E CABG TH ORACIC

8 11 23

167

8

258

40

11

296

5

41

51

28

27

290

39

216

207

171 125

2012

24

2013

2014

2015

Thoracic Robotic Surgery

Advancing Robotics

More than 80 percent of thoracic procedures in 2015 were performed using minimally invasive robotic-assisted surgery, including lobectomies. The ability to use this technology for such a wide range of procedures has yielded some of the shortest lengths of stay for thoracic procedures in Texas, as well as about half of The Society of Thoracic Surgeons’ thoracic surgery database average.1

We have been a national leader in the use of robotics to improve cardiothoracic care. The hospital has deployed the fourthgeneration da Vinci Xi® robot, and has been selected by the manufacturer as one of only a few Observation Epicenters in the world. THHBP hosts physicians and operating room teams from around the nation and internationally to observe cases.

Compared to national data from The Society of Thoracic Surgeons and National Inpatient Sample.

1

THHBP offers thoracic robotic procedures to address: Lung cancer • Mediastinal tumors • Lymphomas • Chest infections with decortications or cancer •

Scar tissue from bypass • Blood flow to the heart (transmyocardial laser revascularization) • Esophageal gastrectomies •

250

236

THORACIC T O TA L S P E R Y E A R

185

173

OPEN/ VAT

20

43

216

207

183 12

R OB OTIC 60

116

99

88

171

160 125

13

2008

2009

2010

2011*

2012

2013

2014

2015

*Thoracic Program Initiated.

25

CV Vascular Surgery

I N - H O S P I TA L S T R O K E A F T E R PRIMARY CEA 2 0 1 5 P E R C E N TA G E

0% THHBP Observed

CEA VS CAS

0.7

%

2 0 1 5 P E R C E N TA G E

0% THHBP Observed

26

0.3% VQI Expected

Our Vascular Surgery Program performed a record number of cases in 2015, with most cases employing minimally invasive endovascular techniques. Length of stays for guests undergoing carotid endarterectomy, carotid stents and endovascular aneurysm repair were generally much shorter than national averages or what would be expected, according to national benchmarking data.

More importantly, THHBP experienced no mortality for three complex vascular procedures, including: •

Carotid endarterectomy

•

Open abdominal aortic resection

•

Type B aortic dissections

THHBP is one of 27 hospitals in the nation to receive three stars, the highest rating possible, from the Vascular Quality Initiative Participation Awards, which are aimed at increasing quality in vascular surgery primarily through reporting and follow-up.

2 0 1 5 P E R C E N TA G E

172

VQI Expected

I N - H O S P I TA L D E AT H A F T E R PRIMARY CEA

Short Lengths of Stay and Few Complications Boost Outcomes and Case Growth.

77.5%

50 22.5% Carotid Carotid Stents Endarterectomy

R E S E A R C H

T R I A L

G R E AT Principal Investigator: Dennis R. Gable, MD GREAT Outcomes Evaluation is a prospective observational cohort registry designed to obtain data on device performance and clinical outcomes of patients treated with GORE endovascular aortic products.

VA S C U L A R V O L U M E S T O TA L S P E R Y E A R APPROACHING 10 YEARS

S UR GIC A L INTER VENTION

1,266 1,018

1,212

1,338

1,392

1,399 531

541 475

496

1,568

1,557

P E R IP HER A L INTER VENTION

492

501

422

361

657

2008

770

2009

790

863

900

2010

2011

2012

1,016

898

2013

2014

1,037

2015

27

Vascular Surgery

Thoracic and Abdominal Aortic Disease

Thoracic Aortic Disease THHBP is home to an innovative regional center for treating complex aortic disease, including aortic dissections and aortic aneurysms of all types and locations. According to The Society of Thoracic Surgeons (STS), outcomes at high-volume thoracic disease treatment programs are typically better than those performed at lower volume centers.

Quality is the hallmark of THHBP’s Thoracic Aortic Disease Program, which features: •

Low mortality rates for both aneurysm and dissections

•

Low reoperative rates for bleeding for both aneurysms and dissections

•

A A A R E PA I R 2 0 1 5 P E R C E N TA G E

EXP OBS

2 0 1 5 P E R C E N TA G E

> 2 D

144 72 78.3% 95%

40 4

Low rate of complications from treatment Endo AAA Repair

28

THORACIC AORTIC OVERALL

Open AAA Repair

18

21.7% 5%

Aneurysm

Dissection

Obse

EXPECTED VS. OBSERVED > 2 D AY S L O S E VA R

Advancing Vascular Disease Treatment Vascular disease specialists on the THHBP medical staff offer minimally invasive repair of thoraco-abdominal aneurysms – a type of aneurysm which often requires open repair at other centers. THHBP also is one of only a handful of places in the region to offer fenestrated endovascular repair for the minimally invasive repair of aortic aneurysms.

This procedure broadens the types of aneurysms that can be treated without major surgery, which often means shorter hospital stays and fewer complications.

R E S E A R C H

T R I A L

DISSECTION Principal Investigator: William Brinkman, MD This is a retrospective study to assess the outcomes of all patients who were diagnosed and had surgery due to Type A acute aortic dissections and compare their outcomes to patients who were transferred from another facility to THHBP or had surgery in another TQI hospital between 1/1/2009–12/31/2014.

EXPECTED VS. OBSERVED > 2 D AY S L O S E VA R

33.2% 18.5% 33.2% 18.5% THHBP Observed

THHBP Observed

VQI Expected

VQI Expected

29

Ellen Q. Sullivan Denton, TX

Former Guest, The Heart Hospital Baylor Plano

Ellen Sullivan had never had heart trouble, but her internist was telling her he heard a heart murmur. An echocardiogram revealed a large ascending aortic aneurysm just above the heart. Without surgery, it could be fatal. At The Heart Hospital Baylor Plano, Ellen underwent surgery to repair the aneurysm with a graft.

“I’m glad I had the surgery to repair my aneurysm. I’m healthier than ever.”

30

CV

ELECTROPHYSIOLOGY T O TA L S P E R Y E A R

Electrophysiology

PAC E MAKE R I MPLAN TAB LE C AR D I O V E RT ER - D E F IB R IL L AT O R EP AB LAT I O N

2,158

2,142

1,980 1,714 1,441

659

673

620

544 484

434

489

450 404

406

Electrophysiology Cases Up Nearly 50 Percent Over the Past Five Years The electrophysiology (EP) team at The Heart Hospital Baylor Plano (THHBP) added new staff to meet growing demand, as well as enhanced processes in the EP lab to further promote best care practices and safety. Additionally, the EP specialists on the medical staff continue to work closely with the hospital’s Valve Program to determine which guests undergoing transcatheter aortic valve replacement may need a pacemaker.

The upcoming expansion of THHBP will add a new EP Lab, further increasing capabilities and the number of guests the EP Program will be able to serve in the future.

1,015

910

980

766

601

2011

R E S E A R C H

2012

2013

2014

2015

T R I A L

reMARQable

Principal Investigator: J. Brian DeVille, MD nMARQTM Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation – Evaluate the nMARQTM catheter system compared with the THERMOCOOL Navigational Family of catheters in treating subjects with paroxysmal atrial fibrillation who still have symptoms with medical treatment.

31

Electrophysiology

Image provided courtesy of Boston Scientific. © 2016 Boston Scientific Corporation or its affiliates. All rights reserved.

Advancing Electrophysiology THHBP, which already offers a robust portfolio of therapies for atrial fibrillation, is among select centers exploring investigational devices for the treatment of atrial fibrillation (Afib).1 These devices seek to allow the ablation of larger areas at one time, which may have the potential to: •

Improve the speed of ablation

Be more effective in eliminating sources of Afib than traditional focal point catheters used for ablation •

In addition, THHBP is also participating in a global, first-ofits-kind study2 looking at the risks and benefits of ablation for patients with persistent Afib.

32

THHBP recently began offering patients with non-valvular atrial fibrillation an alternative to long-term warfarin medication with the recently approved WATCHMAN™ Left Atrial Appendage Closure Implant. The WATCHMAN implant closes off an area of the heart called the left atrial appendage (LAA) to keep harmful blood clots that can form in the LAA from entering the blood stream and potentially causing a stroke. By closing off the LAA, the risk of stroke may be reduced. The WATCHMAN implant procedure usually lasts about an hour, and the patient is typically in the hospital for 24 hours. Patients remain on warfarin for at least 45 days post-procedure until the device endothelializes.

1

reMARQable nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation

2

Evaluation of Multielectrode Phased RF Technology in Persistent Atrial Fibrillation

Darryl Pratt Frisco, TX

Former Guest, The Heart Hospital Baylor Plano

Darryl Pratt nearly died of cardiac arrest while having lunch with a friend in January. Quick thinking from the restaurant manager who began CPR, and paramedics who continued it, saved his life. At The Heart Hospital Baylor Plano, hypothermia treatment saved his brain.

Over the next five weeks, physicians removed a 10 cm clot on his heart, implanted a pacemaker/defibrillator and monitored his vital signs while he remained in a medically induced coma. He woke up on Valentine’s Day. Would his brain still function?

He can answer that. “I’m back at work full time,” he says. “Seeing clients, doing it all.”

“Hypothermia treatment, a pacemaker/defibrillator and outstanding care saved my life.”

33

CV

Cardiac Catheterization

New Procedures and Expanding Programs With more than 4,700 cases performed in the Cath Lab in 2015, THHBP’s Cardiac Catheterization Program has shown a steady uptick in caseloads over the past several years in both categories of diagnostic and coronary interventions.

C AT H L A B T O TA L S P E R Y E A R

C AT H L A B O T H E R / S T R U C T U R A L H E A RT I N T E R V E N T I O N S

C AT H L A B T O TA L S P E R Y E A R

PERIPHERAL INTERVENTIONAL CASES

C AT H L A B OT H E R / PERIPHERAL DIAGNOSTIC CASES S T R U C T U R A L H E A RT I N T E R V E N T I O N S I N T E R V E N T I O N A L C A S E S ( C O R O N A RY180 ) P E R I P HE R A L I N T E R V E N T I O N A L C A S E S D I A G N O S T I C C A S E S ( C O R O N A RY ) P E R I P HE R A L D I A G N O S T I C C A S E S 541

3,715

I NT E R V E NT I O N A L C A S E S ( C O R O N A RY )

Advancing Cardiac Catheterization C A T H L A B

DI A GNOS T I C C A S E S ( C O R O N A RY )

Extensively reviewing every case before and after intervention with both interventional cardiologists on the medical staff and other Cath Lab clinicians •

Determining a strategic approach to treat the CTO based on indications and appropriateness to optimize efficacy and safety

492

4,655

T O TA L S P E R Y E A R

Chronic total occlusions (CTO) are significant coronary artery CATH LAB OTH ER / blockages that present some of the most challenging seenENTIONS STR UCTURAL cases H EART INTERV P ERIP H ERAL INTERV ENTIONAL in the Cath Lab. THHBP’s CTO coronary intervention program is CASES P ERIP H ERAL DIAG NOSTIC CASES expanding with four specialists on the medical staff highly trained INTERV ENTIONAL CASES (CORONARY ) in CTO intervention and a number of processes in place to DIAG NOSTIC CASES (CORONARY ) promote the ideal intervention and outcome, including:

168

210 198

4,121 3,715

4,753

492 210

501

180 541 195

210

195

369

1,124 970

1,207

1,124 970531

180

501

168

541

210

492

195

201 2,081 1,875

1,335 1,207

210

2,368

2,081

1,875

1,124 970

2012

2012

•

2,488

2,368

2,081 1,875

Having a close working relationship with cardiovascular surgeons on the medical staff to determine which CTOs are more appropriate for surgery and which can be addressed through percutaneous intervention •

2012

34

369 3,715 4,121 168

4 4,655

2013

2014

2015

2013

2014

D2B AND D2D2B MEDIAN TIME IN MINUTES

Additionally, the Cath Lab continued to outperform National Cardiovascular Data Registry (NCDR) speed expectations in emergent heart attack cases with door-to-balloon times and LAA, ASD/PFO PROCEDURES door-to-door-to-balloon T O TA L S P E R Y E A R times significantly faster than the respective goals. RapidA Sintervention is critical to preserving heart tissue.

D/ P F O LA A

NCDR TH H B P

107 76

51

60

C O M B I N E D P F O / A S D , M A D E 2 C AT E G O R I E S A N D O B TA I N E D V O L U M E F R O M BOTH SURGICAL AND INTERVENTIONAL

250

LAA, ASD/PFO PROCEDURES T O TA L S P E R Y E A R

AS D / P F O LA A 200

200

198

181

A N D O B TA I N E D V O L U M E F R O M

69

56 70

250

200

100

BALLOON AORTIC V A LV U L O P L A S T Y V O L U M E S T O TA L S P E R Y E A R

105

68

181

200

198

205

80

81

2012

2013

114

69

56

150

Door-to-Door-to-Balloon (D2D2B) (From Transferring Facility) Minutes

C O M B I N E D P F O / A S D , M A D E 2 C AT E G O R I E S BOTH SURGICAL AND INTERVENTIONAL

150

205

Door-to-Balloon (D2B) (THHBP Receiving Facility) Minutes

144

70 128

136

2013 144

2014

2015

68

50 113 100

0

2012

128 50

136

2014

2015

35

CACC Center for Advanced Cardiovascular Care

CLINIC AND IMAGING VOLUMES

16,333

T O TA L S P E R Y E A R

15,496

C L IN IC VIS IT S IM A G IN G P RO CE D URE S

13,480 6,812 6,228

4,375

Advanced Imaging, Advanced Convenience

9,100

The cornerstone of planning for any complex cardiovascular procedure is quality, reliable imaging studies, as well as thorough evaluation and consultation. The Heart Hospital Baylor Plano (THHBP) offers advanced imaging capabilities and comprehensive diagnostic work-ups and treatment planning at guests’ convenience through the outpatient Center for Advanced Cardiovascular Care (CACC).

2,979

3,031

9,521

9,268

9,105 6,121

1,006 2,025

2011

36

2012

2013

2014

2015

T A V R F / U P A N D T TAAVV RR F / U P A N D T A V R INITIAL VOLUMES INITIAL VOLUMES

Through the CACC, guests have access to imaging procedures and technologies that are not widely available.

These studies are available by individual appointment as needed, but also are integrated into weekly clinics at the T O TA L S P E R Y E A R CACC, providing guests the opportunity to receive full diagnostics and a treatment plan in a single visit.

The Heart Valve Center of Texas is one of several clinics in the CACC that offers full evaluations and treatment plans for all types of valve conditions, including advanced aortic valve stenosis.

T O TA L S P E R Y E A R

I NI TI A L F/U P

I NI TI AL F/U P

396 345

396 R E S E A R C H

573

573

287

T R I A L 241

4 D C T TA V R Principal Investigator: Ambarish Gopal, MD 4D CT to Evaluate Valve Thrombosis after Transcatheter Aortic Valve Replacement – Identify the incidence of valve thrombosis in patients referred for 4D CT evaluation due to clinical and/or echocardiographic criteria.

345

174

287

150 121

241

2012

2013

2014

2015

174 150 121

2012

2013

2014

2015 37

Center for Advanced Cardiovascular Care

Advanced Imaging ECHO AND CT VOLUMES

MRI VOLUME*

817

T O TA L S P E R Y E A R

864

T O TA L S P E R Y E A R

3,236

ECHO CT

3,122

2,899 2,340

538

2,178 1,751

455

1,779

1,327 880

98 2011

323

2012

2013

2014

2015

2011

2012

2013

2014

2015

*MRIs are performed at THHBP. 4D CTA Thrombosis Native Aortic Valve

38

4D CTA – TAVR Thrombosis

Bringing Cardiovascular Conditions into Focus Cardiovascular echocardiograms, CT and MRI imaging studies at the CACC (echo and CT) and THHBP (MRI) are provided under the guidance and expertise of imaging specialists on the THHBP medical staff. Some advanced imaging studies include: •

Cardiac MRI viability imaging

•

Myocardial strain imaging

•

Pre-procedural planning and guidance for structural heart procedures

•

Evaluation of valvular heart disease with 4D imaging

Medical Director – Advanced Cardiovascular Imaging CT Program

•

4D CTA of cardiovascular system

Deepika Gopal, MD

•

Coronary CT angiography with fractional flow reserve CT (FFR-CT)

Left to right: Ambarish Gopal, MD

Medical Director – Advanced Cardiovascular Imaging MRI Program Paul Grayburn, MD Medical Director, Noninvasive Cardiology

4D Flow MRI 39

Center for Advanced Cardiovascular Care Clinics Providing Care Across a Broad Spectrum of Conditions The Center for Advanced Cardiovascular Care (CACC) offers various outpatient clinics that provide evaluations and treatment plans across a broad range of diseases and conditions, including:

The Heart Hospital Baylor Plano (THHBP) has initiated an innovative program to address the unique needs of the growing number of adults living with adult congenital heart disease. The program, one of only a handful in the nation, features a dedicated clinic led by a cardiologist on the medical staff who is one of only a small number of physicians in the entire country who are board certified in adult congenital heart disease. The clinic manages ongoing care for guests with adult congenital heart disease, coordinating procedures to help them maintain their health as needed, the most common of which are:

•

Congestive heart failure

•

Vascular disease and the diabetic foot

•

Complex wound care

•

Pulmonary hypertension

•

Thoracic aortic disease

•

Valve disease

•

Heart arrhythmia

•

Inherited cardiovascular disease

Atrial septal defect (ASD)/patent foramen ovale (PFO) closure

•

•

Left atrial appendage (LAA) management

Clinic services are led by physician leaders on the medical staff, nurse practitioners, registered nurses and imaging technologists dedicated to meeting the specific needs of guests on an outpatient basis. If surgical intervention is needed based on the treatment plan, the CACC team works in conjunction with inpatient hospital staff to coordinate hospital care and then outpatient follow-up. There are three CACC locations to serve the Plano, McKinney and Denton areas.

40

Adult Congenital Heart Disease

Advancing Care for Adult Congenital Heart Disease THHBP will be involved in multiple research projects about adult congenital heart disease, a burgeoning subspecialty of cardiovascular medicine. In addition to being the national coordinating site for two multicenter studies – one focusing on treatment outcomes and the other on single ventricle physiology – the clinic will serve as the cornerstone of a Baylor Scott & White Health original study. This study focuses on collecting genetic data on guests with congenital heart disease with the goal of identifying new markers for disease severity and indications for therapy.

Charles Webb Plano, TX

Former Guest, The Heart Hospital Baylor Plano

Charles Webb was diagnosed with congestive heart failure just days after returning from a vacation.

"I was unaware I had anything seriously wrong,” he says. A pacemaker-defibrillator helped for a while, but he needed more. At The Heart Hospital Baylor Plano, he received a left ventricular assist device (LVAD) implant. With help and care post-LVAD at the CACC Heart Failure Clinic, Charles’ life is back on track. “I work out on machines, lift weights and walk 15 minutes on the treadmill,” he says.

“After my LVAD implant, I’m exercising up to four days a week.”

41

ET

Education & Training

For the Next Generation The Heart Hospital Baylor Plano (THHBP) has launched a one-year fellowship program to provide comprehensive training in the management of structural heart disease to two highly qualified fellows. These fellows – one in interventional cardiology and one in cardiothoracic surgery – will work closely with the medical staff to understand and deliver THHBP’s Heart Team approach to care. This intensive fellowship focuses on the clinical evaluation, noninvasive imaging evaluation, medical management, and procedure and post-procedure management of guests with structural heart disease.

42

Exploring Every Angle Fellows will receive quality, in-depth training in every facet of managing structural heart disease, which could help improve care for the thousands of patients each fellow will go on to care for throughout his or her career: •

Outpatient valve clinic

•

Inpatient valve service

•

Noninvasive imaging

•

Cardiac catheterization laboratory

•

Hybrid operating room procedures

•

Robotic mitral and coronary procedures

•

Research

THHBP Fellows in the Structural Heart Fellowship Program:

Sukhdeep Singh Basra, MD

Deborah Tabachnick, MD

Left to right: Kathryn Hobbs Training and Innovation Manager Michael DiMaio, MD Medical Director, Residency/Fellowship Program

43

Women in Heart Disease

From left to right: Deepika Gopal, MD, FACC, FSCCT, FASE, Medical Director, Advanced Cardiovascular Imaging MRI Program

44

Elizabeth Holper, MD, MPH, FACC, FSCAI, Chief Quality Officer Molly Szerlip, MD, FACC, FACP, FSCAI, Medical Director, Inpatient Valve Services

The Trailblazers

Breaking the Mold While Leading the Fight Against Heart Disease Despite the marked increase in the number of female physicians over the past 30 years, women are still significantly underrepresented in the cardiovascular medicine specialties.

In fact, nationally, women comprise only 4 percent of interventional cardiologists1 and a similar percentage of cardiothoracic surgeons. 2 However, at The Heart Hospital Baylor Plano (THHBP), there are 130 female physicians, comprising more than 20 percent of the total medical staff. They have played an indispensable role in delivering quality outcomes to thousands of guests.

Their skill and contributions have helped the hospital earn international acclaim, including honors such as The Society of Thoracic Surgeons’ three-star rating in coronary bypass, aortic valve replacement and combined bypass and valve replacement, among many other accolades.

Female medical staff members are also involved in leading key research initiatives at THHBP. These initiatives are advancing global efforts to combat coronary artery disease, valve disease and a range of other cardiovascular conditions.

130 20% AT THHBP THERE ARE 130 FEMALE PHYSICIANS

COMPRISING 20 PERCENT OF THE TOTAL MEDICAL STAFF

1 Study Finds Women Underrepresented in Interventional Cardiology Field.

The Society for Cardiovascular Angiography and Interventions. 2014.

2 Women Physicians in the Specialties: Making Gains. New England Journal of Medicine Career Center. 2012.

45

Marvin Williams Corinth, TX

Former Guest, The Heart Hospital Baylor Denton

Marvin Williams was doing fine with his pacemaker, but when he went in for a follow-up appointment, he learned he had a bad aortic valve. At The Heart Hospital Baylor Denton, he became the first person in a Denton County hospital to receive an aortic valve replacement through a minimally invasive procedure called a mini sternotomy. “Friends who’ve had heart surgery had their chest opened. That didn’t happen with me.”

“The surgery went beautifully.

I’ve got a three-inch scar, and I’ve never had pain.”

46

2014 THHBD OUTCOMES 2015 THHBD OUTCOMES

282 377

413 612

934 1,493

ADMISSIONS

ED REGISTRATIONS

PATIENT DAYS

1,551 1,624 CARDIOVASCULAR PROCEDURES PERFORMED IN 2014 (CY)

CARDIOVASCULAR PROCEDURES PERFORMED IN 2015 (CY)

105 160 79 120 OPEN HEART

ISOLATED CABG

242 137 1,125 1,207 OTHER SURGICAL

Experiencing Growth and Exceeding Quality Benchmarks The Heart Hospital Baylor Denton (THHBD) is quickly establishing itself as a premier facility for quality cardiac care and service for Denton County residents and surrounding areas all the way north into Southern Oklahoma: • Marked increase in inpatient and ED registrations • Increase in open heart and bypass procedures • 12 percent increase in invasive cardiology procedures • Now the fourth-busiest heart surgery center in Baylor Scott & White Health system • One of only a handful of North Texas hospitals to perform more than 100 open heart surgeries annually

NON-SURGICAL CARDIAC PROCEDURES

47

C A B G C O M P L I C AT I O N R AT E S 8.2%

2015

I N - H O S P I TA L M O R TA L I T Y

THHBD

2015

STS

TH H BD 2.2%

2.3% .8%

.8%

2.2%

.8%

0%

Prolonged Ventilation

0%

Renal Failure

4.7% 3.9%

1.3%

174 150

S TS

2.2%

CVA

Re-op for Bleeding

Any Infection

2.1%

0%

0%

0%

Isolated CABG

Isolated AVR

0%

AVR Plus CABG

Isolated MVR

A V E R A G E L E N G T H O F S TAY 2015

TH H B D

More importantly, even with the climbing caseloads, THHBD quality outcomes remained strong with mortality, average length of stay and key complication rates significantly below averages reported in The Society of Thoracic Surgeons’ national database.

In fact, during its first two years of operation under the THHBD banner, the hospital has had no in-house mortality related to cardiovascular surgery.

48

S TS

10 8.5

6.9

7.2 6.1

4.7

Isolated CABG

4.4

AVR

AVR Plus CABG

4

Isolated MVR

The Heart Hospital Baylor Denton

Press Ganey ® Award In early 2016, THHBD received the Press Ganey Guardian of Excellence AwardSM for Inpatient Satisfaction. The Press Ganey Guardian of Excellence AwardSM is a nationally recognized symbol of achievement in healthcare.

Made for Accolades • Two-star rating from The Society of Thoracic Surgeons for isolated coronary artery bypass grafting • The highest nursing satisfaction scores out of 48 hospitals in the Baylor Scott & White Health system • Named one of the “Top 55 Hospitals Patients Would Definitely Recommend” in the nation by Becker’s Hospital Review

Offering Convenient, Quality Cardiac Care • Cardiothoracic surgery • Cardiac catheterization • Electrophysiology • Comprehensive wound care management and limb preservation

Five-star rating* for “Overall Patients’ Experiences” by Centers for Medicare & Medicaid Services (CMS)

• Vascular and endovascular surgery • Advanced imaging *Ratings based on CMS reporting. Visit www.medicare.gov/hospitalcompare for full details.

Ratings based on CMS website for periods 7.1.14 through 6.30.15.

49

Jerry Neighbors Valley View, TX

Former Guest, The Heart Hospital Baylor Denton

Jerry Neighbors’ angina just wouldn’t go away, so he stopped by a neighborhood urgent care clinic. They immediately sent him to The Heart Hospital Baylor Denton, where an angiogram revealed that several arteries were blocked up to 90 percent. “Going there was the best move I ever made,” he says. Within a few days, he received four coronary artery bypass grafts. That was just five months ago. Now, he says, “I’m pretty much back to 100 percent.

I’m sure it’s because of the great care I received.”

“I recovered so fast from my quadruple bypass, it even surprised the nurses.”

50

The Heart Hospital Baylor Denton D AY S T O H E A L & H E A L I N G P E R C E N TA G E C WV C WO U N D E X P E RT ®

99.68%

95.44%

B E N C H MA R K

60

Hyperbaric oxygen therapy (HBO) is an integral treatment modality at the Comprehensive Wound & Vascular Center.

Healing Rate Five Days Faster than the National Average* The Center for Advanced Cardiovascular Care (CACC) in Denton is owned and operated as a department of THHBD, and it offers the only complex wound care center in Denton County – the Comprehensive Wound & Vascular Center (CWVC). The CWVC offers services for the diagnosis, treatment and management of complex non-healing wounds through a wide range of approaches, with specialty focus on limb preservation and hyperbaric therapy.

65

Days to Heal

Healing Percentage

Soon, the CACC in Denton will also offer cardiac rehabilitation services. Modeled after the cardiac rehab program at The Heart Hospital Baylor Plano, the Denton program will focus on helping guests rebuild physical strength and maintain a healthy lifestyle after a cardiac event or cardiovascular surgery. The program will be equally appropriate for guests with chronic conditions, such as coronary artery disease or heart failure, who can benefit from exercise and risk factor modification.

*Palliative/malignant wounds were not included in the days to heal/healing percentage. 2015 WoundExpert® Database: Net Health’s WoundExpert is certified as a Complete Electronic Health Record (EHR) by the Drummond Group, an ONC-ATCB testing entity.

51

The Heart Hospital Baylor Plano

Research Team

The Heart Hospital Baylor Plano Research Team Pictured from left to right: Front: Jackie Ward, CRC; Trisha Todd, RN, BSN; Holly Neatherlin, MSN, RN; Michael DiMaio, MD, Medical Director, Residency/Fellowship Program; David L. Brown, MD, President of Medical Affairs; Molly Szerlip, MD, Medical Director, Inpatient Valve Service; Michael J. Mack, MD, Baylor Scott & White Health, Medical Director, Cardiovascular Services; Rachelle Winkle, RN, BSN; Katherine Hebeler, BA; Natalia Féliz; Haley Boswell, BS, ED; Julie McCracken, BS; Middle: Megan White, CCRC, BA; Lesia R. Parker, Research Analyst; Sarah Lam, RN; Elizabeth Holper, MD, MPH, FACC, FSCAI, Chief Quality Officer; Srini P. Potluri, MD, Medical Director, Cardiac Catheterization Laboratory; Esperanza Jackson; Renesa Whitman, CCRC, BS; Necole Kell, RN; Amanda Fenlon; Lucy Miranda; Audrey Anderson; Back: Tina Worley, RN, BSN, CCRC; Penni Dolton, RN, BSN; Jack Squiers, BSE; Jennifer Swim; Heike Baumgarten, HD; Brittany Zingler, RN, BSN; Tricia Snelus, CCRC; Ali Biberstein, RN, BSN; Melissa Johnson, CCRC; Jennifer Fox; Jesse Tarbutton, CRC; C. Yvette King, CIM, CCRP; Bridgette Obokhae, BS; Cecile Mahoney, BS, CCRP

52

C O R O N A R Y

A R T E R Y

D I S E A S E

C H R O N I C T O TA L O C C L U S I O N Principal Investigator: Srini P. Potluri, MD

Since 2008, nearly 3,000 patients have participated in clinical trials conducted through The Heart Hospital Baylor Plano. In that time, we have completed more than 50 trials and have 75 active clinical trials.* Baylor Scott & White Research Institute (BSWRI) is accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), which is a voluntary, peer-driven and educationally based model of accreditation. The BSWRI team at The Heart Hospital Baylor Plano is backed by the expansive BSWRI network, which has more than 3,000 board-certified physicians, including approximately 500 active research investigators experienced in drug, device and vaccine studies.

C A R D I O L O G Y ARTEMIS Principal Investigator: David L. Brown, MD Affordability and Real-World Antiplatelet Treatment Effectiveness – Assess the impact of copayment reduction by equalizing the copayment of clopidogrel and ticagrelor.

Will assess prescribing patterns, patient medication adherence and clinical outcomes up to one year.

RADIANCE Principal Investigator: Srini P. Potluri, MD The “Radiance-HTN” Study – A Study of the ReCor Medical Paradise System in Clinical Hypertension – Demonstrate the ability of the Paradise System to effectively reduce systolic daytime ambulatory BP (ABP) in hypertensive subjects.

This is a prospective registry of all patients at The Heart Hospital Baylor Plano who undergo attempt at coronary CTO intervention.

E V O LV E Principal Investigator: Molly Szerlip, MD Assess the safety of three-month DAPT in subjects at high risk for bleeding undergoing PCI with the SYNERGY Stent System.

LEVO-CTS Principal Investigator: Randy Marcel, MD Evaluate if an investigational medicine, called LEVOSIMENDAN, is safe and effective in patients with left ventricular systolic dysfunction who are undergoing cardiac surgery on cardiopulmonary bypass.

RESOLUTE INTEGRITY Principal Investigator: Srini P. Potluri, MD Resolute Integrity US Extended Length Sub-Study (RI-US XL) – Conduct a prospective, multicenter evaluation of the procedural and clinical outcomes of subjects that are treated with the commercially available 34 MM and 38 MM Medtronic Resolute Integrity ZOTAROLIMUS-ELUTING coronary stem system.

Extended Length Sub-Study (RI-US XL E teLIntegrity E C US T R O P H Y S I O L O G Y ADAPT Principal Investigator: Hafiza H. Khan, MD Adapt Response Clinical Trial – Test the hypothesis that market-released CRT devices which contain the ADAPTIVE CRT algorithm have a superior outcome compared to standard CRT devices and CRT-indicated patients with normal AV conduction in left bundle branch block. *Not all active clinical trials are listed.

53

THHBP Research

CABANA Principal Investigator: J. Brian DeVille, MD

L A R I AT ® Principal Investigator: J. Brian DeVille, MD

Catheter Ablation versus Anti-Arrhythmic Drug Therapy for Atrial Fibrillation (AF) Trial – Test the hypothesis that the treatment strategy of left atrial catheter ablation for the purpose of eliminating AF will be superior to the current therapy with either rate control or rhythm control drugs for reducing total mortality in patients with untreated or incompletely treated AF.

Left Atrial Appendage Closure with SentreHeart Lariat ® Device – Primary aim is to assess the outcome of patients undergoing left atrial appendage ligation or closure with the SentreHeart Lariat device as a stand-alone procedure at the participating centers.

CARELINK EXPRESS Principal Investigator: J. Brian DeVille, MD Determine if evaluating CIEDs using CareLink Express® can lead to shorter time to interrogation in the Emergency Department compared to evaluation of devices using traditional evaluation procedures.

Medtronic Product Surveillance Registry (Cardiac Rhythm) – Purpose of this registry is to better understand the safety and effectiveness of Medtronic market-released products.

C AT H E T E R A B L AT I O N Principal Investigator: J. Brian DeVille, MD This is a retrospective study to describe the population of patients at THHBP who have undergone percutaneous ablation for atrial arrhythmias following failed surgical ablation from 2007–2015.

ENHANCE Principal Investigator: Trieu Q. Ho, MD CRT Implant Strategy Using the Longest Electrical Delay for Non-LBBB Patients – Purpose is to analyze the effect of the left ventricular lead pacing location and the non-left bundle branch block in heart failure patient population.

54

PA N Principal Investigator: J. Brian DeVille, MD

POAF MVR Principal Investigator: James Edgerton, MD This is a prospective study to assess the incidence of new Afib events after discharge in patients with isolated post-MVR Afib at THHBP between 9/1/2015–8/30/2016.

QUARTET 1457Q Principal Investigator: Adam Shapira, MD Assess the safety of the St. Jude Medical™ 1457Q Quartet™ Quadripolar LV lead at three months in a patient population indicated for cardiac resynchronization.

VICTORY AF Principal Investigator: J. Brian DeVille, MD Evaluation of the Phased Radiofrequency Ablation System – The purpose of this clinical study is to evaluate the risk of procedure and/or device-related strokes in subjects with persistent or long-standing, persistent Afib, undergoing ablation with the Phased RF System.

H E A R T

F A I L U R E

H E A R T M AT E I I I Principal Investigator: Brian Lima, MD Evaluate the safety and efficacy of injecting MPCs (150 million dose) into the native myocardium of LVAD recipients.

P U L M O N A R Y

H Y P E R T E N S I O N

OPUS Principal Investigator: Sahil Bakshi, DO OPsumit USers Registry – Registry developed to characterize the safety profile (including primarily potential serious hepatic risk) and to describe clinical characteristics and outcomes of patients with pulmonary hypertension who are newly treated with Opsumit in the post-market setting.

PA H B I O B A N K Principal Investigator: Sahil Bakshi, DO

COAPT Principal Investigator: Paul Grayburn, MD Cardiovascular Outcomes Assessment of the MitraClip® Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation – Compare the performance of the investigational MitraClip® system plus optimal drug therapy with optimal drug therapy alone.

CTSN-TRICUSPID Principal Investigator: Robert L. Smith II, MD Evaluate the efficacy and safety of performing tricuspid valve (TV) repair in patients undergoing mitral valve surgery with either moderate tricuspid regurgitation (TR) or less than moderate TR with tricuspid annular dilation.

E N D O C A R D I T I S - S H O R T- T E R M Principal Investigator: J. Michael DiMaio, MD This is a retrospective study to assess the short-term outcomes of patients who underwent valve surgery for infective endocarditis (IE) versus patients who underwent valve surgery without IE in the Baylor Scott & White system from 2004–2013.

National Biological Sample and Data Repository for Pulmonary Arterial Hypertension – Establish a national biorepository of biological samples and genetic data of patients with WHO Group 1 PAH.

MAC Principal Investigator: Srini P. Potluri, MD

V A L V E

This is a retrospective study to analyze and quantify the degree of mitral annulus calcification (MAC) in patients undergoing TAVR at THHBP between 11/1/2011–11/1/2015.

S U R G E R Y

B E N TA L L V S . VA LV E S PA R I N G Principal Investigator: William Brinkman, MD This is a retrospective study to compare postoperative outcomes between patients who underwent Bentall or VSRR procedure at THHBP between 1/1/2009–6/1/2015.

C A R D I O C E L ®- T R I - L E A F L E T Principal Investigator: William T. Brinkman, MD

THE MITRAL EXPERIENCE Principal Investigator: Robert L. Smith, MD This is a retrospective study to compare the outcome and treatment costs of all patients who underwent isolated MVR either using a minithoracotomy or robotic approach at THHBP between 1/1/2007–12/31/2015.

Will quantify the safety and efficacy of the CardioCel® implant in tri-leaflet repair.

55

THHBP Research

MITRAL GRADIENT Principal Investigator: Srini P. Potluri, MD

P V L I N TA V R Principal Investigator: Deepika Gopal, MD

This is a retrospective study to analyze how the TAVR procedure affects mitral gradient from baseline compared to postoperatively at one month and one year in patients who underwent TAVR at THHBP between 11/1/2011–11/1/2015.

A Novel Imaging Approach to Assess Paravalvular Leak for Transcatheter Valve Replacement – Assess the agreement between cMRI PVL grading (based on regurgitant fraction) and TTE PVL grading (based on pressure, half-time and the ratio of the jet arch to the circumference of the annulus).

MR GRADING Principal Investigator: Paul Grayburn, MD This is a retrospective study to develop a mitral regurgitation (MR) score for secondary MR grading and verify the score on patients who underwent echocardiographic assessment at THHBP and BHVH between 1/1/2007–6/30/2013.

This is a retrospective study to compare the outcomes of all patients who underwent the Ross procedure or had a prosthetic aortic root replacement at THHBP between 1/1/2007–12/31/2014.

NEUROPROTECTION Principal Investigator: Michael Mack, MD

SALUS-DIRECT FLOW Principal Investigators: David L. Brown, MD/William T. Brinkman, MD

Neuroprotection in Patients Undergoing Aortic Valve Replacement – Primary aim of this study is to evaluate the efficacy and safety of embolic protection devices to reduce ischemic brain injury in patients undergoing surgical aortic valve replacement.

Demonstrate the safety and effectiveness of the Direct Flow Medical® Transcatheter Aortic Valve System in subjects with severe aortic stenosis who are considered extreme or high risk for surgical valve replacement.

PA R T N E R I I Principal Investigators: David L. Brown, MD/William T. Brinkman, MD

S U R TA V I Principal Investigators: William H. Ryan III, MD/David L. Brown, MD

The Partner II Trial: Placement of Aortic Transcatheter Valves – Establish the safety and effectiveness of the Edwards Sapien XT and the Edwards Sapien 3 transcatheter heart valve device and delivery systems, which are intended for use in patients with symptomatic, calcific, severe aortic stenosis.

A prospective study evaluating TAVR with the Medtronic Evolut/CoreValve® in intermediaterisk patients with severe aortic stenosis. Patients are randomized 1:1 between TAVR and SAVR. Follow-up is through five years.

PORTICO Principal Investigators: David L. Brown, MD/William T. Brinkman, MD Portico™ Re-sheathable Transcatheter Aortic Valve System US IDE Trial – Evaluate the safety and effectiveness of the SJM Portico Transcatheter Heart Valve and Delivery Systems (Portico) via transfemoral and alternative delivery methods.

56

ROSS/ROOT Principal Investigator: William H. Ryan III, MD

TRANSFORM Principal Investigator: William H. Ryan III, MD Multicenter Experience with the Rapid Deployment EDWARDS INTUITY Valve System For Aortic Valve Replacement – Assess the safety and effectiveness of the EDWARDS INTUITY Valve System in subjects with aortic stenosis or stenosis-insufficiency requiring primary replacement of the native aortic valve.

V A S C U L A R

S U R G E R Y

E VA S I ( N E L L I X ® ) Principal Investigator: Jay Vasquez Jr., MD A prospective, multicenter, single-arm safety and effectiveness study of endovascular abdominal aortic aneurysm repair using the Nellix system: pivotal and continued access study.

EXCLUDER Principal Investigator: William P. Shutze III, MD Evaluation of the GORE® EXCLUDER® Iliac Branch Endoprosthesis for the Treatment of Common Iliac Artery Aneurysms or Aorto-Iliac Aneurysms – Designed to assess the safety and efficacy of the IBE device in subjects with common iliac artery aneurysms or aorto-iliac aneurysms.

IVUS Principal Investigator: William P. Shutze III, MD A Prospective Randomized Feasibility Trial Comparing Angiography and Angiography with IVUS for treatment of hemodialysis access failures – Determine if the data IVUS provides is able to recognize lesions that would have gone untreated and to determine whether or not this impacts outcomes.

VA L I A N T E V O Principal Investigator: William T. Brinkman, MD Valiant Evo Thoracic Stent Graft System – Demonstrate the safety and effectiveness of the Valiant Evo Thoracic Stent Graft System in subjects with a descending thoracic aortic aneurysm (DTAA) who are candidates for endovascular repair.

VA S C U L A R P O S T M A R K E T R E V I E W Principal Investigator: Dennis R. Gable, MD Vascular Post Market Review – CardioCel ® CEA – Confirm that properties of CardioCel® provide operative benefit to surgeons when compared to Dacron, CorMatrix and all other bovine pericardium not treated with proprietary ADAPT engineering.

WISCR Principal Investigator: Dennis R. Gable, MD Designed to collect clinical reference images using the study device (Spectral MD DeepView Wound Imaging System 2.0) in subjects with a variety of acute and chronic wounds.

THORAFLEX HYBRID Principal Investigator: William T. Brinkman, MD Evaluation of the Thoraflex™ Hybrid Device – Assess the effectiveness and safety of the Thoraflex Hybrid device in the treatment of aortic disease affecting the aortic arch and the descending aorta, with or without involvement of the ascending aorta.

57

Board of Managers

Glenn B. Callison

David J. Ballard, MD, MSPH, PhD

David L. Brown, MD, FACC, FACP

Dennis R. Gable, MD, RVT

Srinivas R. Gunukula, MD, FACC

John McWhorter

James Peacock

William H. Ryan III, MD

Robert L. Smith II, MD

Janie Wade

David Winter, MD

Samuel C. Woolbert, MD, FACC

Liz Youngblood

Chairman

58

Tea E. Acuff, MD

Richard T. Bowman, MD

Robert F. Hebeler, Jr., MD

THORACIC & CARDIOVASCULAR SURGERY

William T. Brinkman, MD, Medical Director, CACC/Thoracic Aortic Disease Center, THHBP

Tung H. Cai, MD,

Kelley A. Hutcheson, MD

G. Kimble Jett, MD,

James R. Edgerton, MD

Katherine B. Harrington, MD

Michael Mack, MD,

David O. Moore, MD,

Medical Director, Cardiothoracic Surgery Program, THHBD

Medical Director, Thoracic Surgery Program, THHBP

Medical Director, Cardiovascular Services, Baylor Scott & White Health

Physician Partners

Physician Partners

Medical Director, Physician Champion in Patient Safety, THHBP

VASCULAR SURGERY

Not Pictured: Vickie L. Chappell, MD Robert J. Wilcott, MD

William H. Ryan III, MD, Chairman, Cardiovascular Surgical Services, THHBP

Robert L. Smith II, MD, Vice Chair, Cardiovascular Surgical Services, THHBP

Dennis R. Gable, MD, RVT, Chairman of Vascular Surgery, THHBP

Bradley R. Grimsley, MD

59

Physician Partners

Stephen E. Hohmann, MD

John C. Kedora, MD,

Warrett Kennard, MD

Vice Chairman of Vascular

VASCULAR SURGERY

William P. Shutze, III, MD, Chairman of Credentials

Bertram L. Smith, III, MD

Jay Vasquez, Jr., MD, PA

Kanti L. Agrawal, MD

Saleem Akbar, MD

Surgical Services, THHBP

INTERVENTIONAL CARDIOLOGY

Not Pictured: Robert H. Connaughton, MD Carlos Cruz, MD

Wael Abo-Auda, MD

Franklin S. Yau, MD

Venkata R. Aligeti, MD

60

Neeraj Arora, MD

James D. Boehrer, MD

Poonam G. Agarwal, MD

Bruce S. Bowers, MD

David L. Brown, MD President of Medical Staff Affairs, THHBP, THHBD

Physician Partners

Manuel W. Cruz, MD

Eric J. Eichhorn, MD

Gary P. Fazio, MD,

INTERVENTIONAL CARDIOLOGY

Alistair I. Fyfe, MD, PhD

Luisa Y. Gan, MD

Medical Director, Cardiology Services, THHBD

Bruce M. Gordon, DO,

Srinivas R. Gunukula, MD,

Medical Director, Advanced Cardiovascular Imaging CT Program, THHBP

Medical Director, Cardiac Catheterization Laboratory, THHBD

Medical Director, CACC/Outpatient Imaging, THHBP

Elizabeth Holper, MD,

Michael G. Isaac, MD

Abraham Jacob, MD

Ambarish Gopal, MD,

Chief Quality Officer, THHBP

Jeffrey R. Gladden, MD, Medical Director, Cardiac Rehab, Heart Attack & Stroke Prevention, THHBP

Ricky L. Harris, DO

Phillip J. Hecht, MD, PA

John S. Hollowell, MD

Vishnu V. Kalidindi, MD

Jeff D. Kaplan, MD,

Farhana Kazi, MD

Chairman of Peer Review, THHBD

61

Physician Partners

62

INTERVENTIONAL CARDIOLOGY

Patrick L. Kennedy, MD

Hema L. Korlakunta , MD

S. Raju Kosuri, MD

J.W. Randolph Lawson, MD

Robert Liao, MD

Prasad V. Maddukuri, MD

Saleem H. Mallick, MD

Winston S. Marshall, MD

Joseph A. Meacham, MD

Larry C. Moore, MD

Philip A. Morales, MD

Biren H. Parikh, MD

R. Conrad Park, MD,

Norvin G. Parr, III, MD

Prasad V. Paturu, MD

Trent L. Pettijohn, MD,

Neil N. Phung, MD

Prem S. Pillay, MD

Medical Director, Vice President of Medical Staff Affairs (CMO), THHBD

Vice President of Medical Staff Affairs (CMO), THHBP

Physician Partners

Srini P. Potluri, MD, Medical Director, Cardiac Catheterization Laboratory, THHBP

David W. Prewitt, MD

Srinivas A. Reddy, MD

Brian G. Schwartz, MD

David A. Schwartz, MD

Dhiren L. Shah, MD

INTERVENTIONAL CARDIOLOGY

J. Edward Rosenthal, MD

Rolando M. Solis, MD

Raul A. Santos, MD

David M. Scherer, MD, PA

Molly Szerlip, MD,

Kevin P. Theleman, MD

Medical Director, Inpatient Valve Services, THHBP

Not Pictured:

Scott C. Turner, DO

Jai Varma, MD

Thomas A. Waller, MD

Samuel C. Woolbert, MD Chairman, Cardiovascular Medicine, THHBP

Donald D. Wurzburg, MD

Richard F. Ammar, Jr., MD Mario A. Bonilla, MD Jacob Chemmalakuzhy, MD Christopher B. Cianci, DO Saritha Dodla, MD David A. Engleman, MD Aravind Gangasani, MD Fayak S. Kamili, MD Asad Karim, MD M. Akram Khan, MD Sameh Sayfo, MD Mukesh R. Sheth, MD Sabrina Stone, MD Faisal Wahid, MD Martin S. Weiss, DO

63

Physician Partners

Thomas P. Beveridge, MD

Brian T. Blatt, DO

J. Brian DeVille, MD, Co-medical Director, Electrophysiology, Baylor Scott & White Health

ELECTROPHYSIOLOGY

David N. Edwards, MD, PhD,

Scott L. Greenberg, MD

Baylor Research Institute Research Medical Director, Arrhythmia and Genetics Research

Not Pictured: Mustafa Dohadwala, MD Trieu Q. Ho, MD Amena Hussain, MD

Hafiza H. Khan, MD

Adam R. Shapira, MD,

Rajesh B. Vrushab, MD

Medical Director, Electrophysiology, THHBP

NONINVASIVE CARDIOLOGY

Simon N. Allo, MD

64

Sahil Bakshi, DO, Medical Director, Pulmonary Hypertension Center, EHR Champion, THHBP

Vidyasagar Chodimella, MD

David F. Davis, MD

Deepika Gopal, MD, Medical Director, Advanced Cardiovascular Imaging MRI Program, THHBP

Jodie L. Hurwitz, MD

Physician Partners

NONINVASIVE CARDIOLOGY

M. Kevin Graves, MD

Paul A. Grayburn, MD, Medical Director, Noninvasive Cardiology, THHBP

Marun S. Haddad, MD

Vikas C. Jain, MD

Ramarao S. Lankipalli, MD

Marcus E. McKenzie, MD

Waenard L. Miller, MD

Steven Mottl, DO,

Rad G. Nair, MD

David A. Rawitscher, MD,

Jose M. Rivera, MD

Sarah A. Samaan, MD

Medical Director, Congestive Heart Failure Center, THHBP

Medical Director, Noninvasive Cardiology, THHBD

Not Pictured: John E. Reuter, MD

Manisha J. Shah, MD

Marc S. Shalek, MD, Co-chairman of Peer Review, THHBP

65

MEDICAL STAFF ADVANCED PRACTICE PROFESSIONAL Abraham, Jai, ACNP • Alexander, Jennifer PA-BC • Baxter, Lindsey E., AGACNP • Bradford, Monique L., ANP • Caras, LuAnn I., ACNP • Forst, Stacy A., ACNP • Grayson, Gabriell N., ACNP • Guajardo, Terri L., ACNP • Hartley, Mary K., ACNP • Hildebrand, Clint, PA-BC • Jalloh, Fatmata, AGACNP • Laine, Jason P., ACNP • McAlister, Diana L., ANP • Nermal, Nerchi, AGACNP • Ngo, Khanh H., PAC • Ojeda-De los Santos, Melissa, ACNP • Romero, Alejandro, PA-BC • Smith, Aneicha, AGACNP • Sulkin, Lee M., ANP • Tinnerman, Erin, PA-BC • Vien, Adrienne T., PAC • Vintinner, Jacob, PA-BC • Walsh, Amy, PA-BC • Wilson, Gretchen, PA-BC • Zurawski, Ranae M., ACNP •

ANESTHESIOLOGY Ackerman, David S., MD • Adams, Thomas Jr., MD • Aleem, Mohammed A., DO • Assadi, Mohammed A., MD • Boehler, Lillian M., MD • Bond, Ninetta M., MD • Boulanger, Kristine S., MD • Bulger, Robert R., MD • Burton, Laura B., MD • Cade, Aaron M., MD • Chi, Lei, MD • Cohen, Seth, DO • Coleman, Robyn G., MD •

66

Craig-McMurtry, Kelli E., MD • Desai, Ronak K., MD • DiGiovanni, David A., MD • Dullye, Larry J. II, DO • Ellermeyer, William P., MD • Fox, Leonidas G., MD • Gathe-Ghermay, Joy C., MD • Gilly, Michael D. Jr., MD • Gootos, Peter J. II, MD • Griffin, Julia, MD • Harvey, Benjamin J., DO • Higgins, Jennifer B., MD • Hoffman, William J., MD • Horswell, Jeffrey L., MD • Huss, Michael G., MD • Hussain, Asadullah, MD • Jahani, Mehrnoosh, DO • Jahani, Minoo, DO • Lacour, Thomas A. Jr., MD • Latson, Terry W., MD • Lee, Miriam E., MD • Lodes, Kirk J., MD • Lowe, Kevin B., MD • Lowe, Mark S., MD • Marcel, Randy J., MD • Marlowe, Brannon D., MD • Maydew, Randall P., MD • McVay, Travis J., MD • Merritt, Nathan H., MD • Michelsen, Luis G., MD • Morris, Joseph J. Jr., MD • Mueller, James B., MD • Nance, Jeff E. III, MD • Needleman, Steven M., MD • Nguyen, Hoang D., MD • Njo, Lucas, MD • Ogbue, Patrick O., MD • Padakandla, Udaya B., MD • Pailes, Nathan A., MD • Pohar, Selvi M., MD • Quinones, Hector L., MD • Raccasi, Mark A., MD • Ranson, Brian J., DO • Reed, Scott E., MD •

Reynolds, Justin H., DO • Richmond, Kim B., DO • Robbins, Randy L., MD • Ronderos, Jaime R., MD • Sanga, Raghuram, MD • Saye, Timothy D., MD • Scott, John S. Jr., DO • Shah, Arjav J., MD • Sigurdsson, Sigurdur S., MD • Singleton, Terrica R., MD • Speers, Cynthia W., MD • Steffey, Clinton S., MD • Thomas, Kevin F., MD • Tonrey, Frank G., MD • Villarreal, Mark C., MD • Vu, Giac T., MD • Vu, Phat T., MD • Vuppalanchi, Madhuri, MD • Walsh, Michael J., MD • Watkins, Richard M., MD • Webb, Jerry L., MD • White, Lindsey K., MD • Wiley, Casey B., MD • Wong, Alvin P., MD • Youn, Paul Y., MD • Zietz, Danielle F., DO •

CARDIOLOGY, NONINVASIVE Agrawal, Kanti L., MD • Akbar, Saleem, MD • Allo, Simon N., MD • Bakshi, Sahil, DO • Bavikati, Neeta, MD • Bonilla, Mario A., MD • Carry, Melissa M., MD • Cedars, Ari M., MD • Chodimella, Vidyasagar, MD • Davis, David F., MD • Dodla, Saritha, MD • Duncan, John W., MD • Evans, Matthew R., MD • Gopalakrishnan, Deepika, MD •

•

PLANO

•

DENTON

Graves, Max K., MD • Grayburn, Paul A., MD • Haddad, Marun S., MD • Hall, Randall S., DO • Hall, Shelley A., MD • Haynie, David P., MD • Henderson, Eugene B. Jr., MD • Iftikhar, Faizan, MD • Jain, Vikas C., MD • Kaplan, Jeffrey D., MD • Khan, Mubashar H., MD • Lankipalli, Rama Rao S., MD • Mandell, Ryan S., DO • McCullough, Peter A., MD • McKenzie, Marcus E., MD • Miller, Waenard L., MD • Mottl, Steven D. Jr., DO • Nair, Arjun, MD • Nair, Radhakrishnan G., MD • Phung, Neil N., MD • Pieniek, Marc S., MD • Pillai, Narayn, MD • Pillarisetti, Jayasree, MD • Rawitscher, David A., MD • Reuter, John E., MD • Rivera, Jose M., MD • Roffman, Joel A., MD • Samaan, Sarah A., MD • Sarmast, Syed A., MD • Schwartz, Brian G., MD • Shah, Manisha J., MD • Shalek, Marc S., MD • Vidi, Venkatesan D., MD • Viqar-Syed, Maria, MD •

CLINICAL NEUROPHYSIOLOGY Tadia, Riaz Y., MD

•

CLINICAL PATHOLOGY Bajaj, Jaya, MD • Bannister, Paul, MD • Black, Michael E., MD •

• PLANO & DENTON

Dobson, Robin W., MD • Gill, Javed I., MD • Kanhere, Rujuta A., MD • Keglovits, Latoya G., MD • Leday, Temekka V., MD • Mays, Edward J. III, MD • Middleman, Benton R., MD • Neumann, William L., MD • Punar, Metin, MD • Reed, Jason T., MD • Savino, Daniel A., MD • Simon, Walter B., MD • Vuica-Ross, Milena, MD • Wenceslao, Stella M., MD • Winneberger, Linda J., MD •

CRITICAL CARE MEDICINE Waldo, Rick T., MD

•

DIAGNOSTIC RADIOLOGY Arraut, Alfredo L., MD • Bakshi, Tracy R., MD • Benson, Eric H., MD • Bondy, John D., MD • Boren, Edwin L. Jr., MD • Boyce, Daniel, MD • Burtea, Iulian M., MD • Carenza, Jeffrey W., MD • Chaudhry, Sadaf, MD • Chen, Henry T., MD • Chicoskie, Christopher J., MD Chitkara, Pranav, MD • Chu, Vincent, MD • Clark, Jeremy D., DO • Colby, Ethan, MD • Davis, Eric, MD • Diebner, Jeffrey D., MD • Donohoe, Amanda C., MD • Driskill, Lance E., MD • Elkins, William N. III, MD • Fritts, Aaron H., MD •

•

Goscin, Christopher P., MD • Greenberg, Jeffrey E., MD • Greenway, Kathryn A., MD • Guinn, Todd B., MD • Hernandez, Ryan J., MD • Herrera, Mark E., MD • Ho, Jeffrey C., MD • Hochman, Jesse N., MD • Jackson, Lawson A. Jr., MD • Jones, Blaise W., MD • Kapoor, Vipul, MD • Khasgiwala, Vaibhav C., MD • Kim, David H., MD • Kim, John Y., MD • Klamer, David L., MD • La, Samuel S., MD • Li, Chun-Der, MD • Liu, Heng-Hsiao E., MD • Ma, Jason, MD • Maiers, Michael J., MD • Martin, Warren C., MD • Mayne, Jennifer C., MD • McGinnis, Leslie A., MD • McKernan, Margaret G., MD • Metzler, Jonathan P., MD • Miller, Brian R., MD • Mishra, Michael D., MD • Moger, Adrian C., MD • Morris, Bruce J., MD • Mulloy, John P., MD • Nguyen, Nam T., MD • Nisbet, Robert J., MD • Pachnanda, Alexander A., MD • Priddy, Nathan, MD • Quarles, Bryan S., MD • Reiman, Steven R., MD • Sanders, Clayton J., MD • Scimeca, Tyler R., MD • Seaberg, Elizabeth A., MD • Seaberg, Karen M., MD • Sedrak, Lori A., DO • Sedrak, Peter, MD • Sharp, Jason W., MD • Shin, Victor, MD •

Singhal, Anupam K., MD • Small, Andrew B. IV, MD • Spivey, Mark A., MD • Staveteig, Paul T., MD • Sullivan, John P., MD • Taten, Allison C., MD • Thompson, Buddy G., MD • Tschoepe, Ernest J., MD • Varma, Neel B., MD • Vincent, Dale C., MD • Vuong, Cuong T., MD • Webb, Gary L., MD • Wen, Ted S., MD • Whisenant, Justin T., MD • Whitworth, Melissa A., MD • Wolf, Jason L., MD • Wooten, Edward W., MD • Worsham, Austen W., MD • Wu, Francis M., MD • Zerner, James J., MD • Zogg, Morna J., MD •

EMERGENCY MEDICINE

ELECTROPHYSIOLOGY Abrol, Rajjit, MD • Beveridge, Thomas P., MD • Blatt, Brian T., DO • Chhabra, Sumeet K., MD • DeVille, J. Brian, MD • Dohadwala, Mustafa, MD • Edwards, David N., MD • Greenberg, Scott L., MD • Hurwitz, Jodie L., MD • Hussain, Amena, MD • Joshi, Rajeev, MD • Khan, Hafiza H., MD • Kizilbash, Ali M., MD • Naseem, Rao H., MD • Owens, Andrew W., MD • Rizvi, Kamran, MD • Shamim, Sadat A., MD • Shapira, Adam R., MD • Vrushab, Rajesh B., MD • Yoo, Dale, MD •

•

Bean, Lawrence A., MD • Bedi, Sagar, MD • Bleier, Joseph T., MD • Caldera-Nieves, Javier R., MD • Carrothers, Irene A., MD • Compton, Paul A., MD • Dasa, Sridevi L., MD • Dharamsi, Farid, MD • Diamond, David S., DO • Dickson, Matthew, MD • Duncan, Kokie T., DO • Fagan, Elizabeth L., MD • Frazer, Jacqueline A., MD • Garrett, John S., MD • Gicheru, Eugene K., MD • Gregory, Linda, DO • Hamilton, Mark J., MD • Hassani, Dahlia M., MD • Haynes, Shane P., MD • Holt, Jonathan D., MD • Jensen, Ronald J., DO • Jimenez, Harold E., MD • Kahn, Andy, MD • King, John K., MD • Marcucci, John F., MD • Mirza, Umarfarook J., DO • Morgan, James A., MD • Mosely, Erica M., MD • Nazeer, Shameem R., MD • Passi, Jatinder P., MD • Peters, Nick P., MD • Pidgeon, Leslie K., DO • Quach, Minh T., DO • Rosillo, Jose R., MD • Shahani, Samir N., MD • Shayesteh, Amid, DO • Sheena, Douglas A., MD • Sok, Rithy, DO • Stephenson, Trenton A., DO • Sumrall, Joseph C., DO • Tran, Quyen H., MD •

PLANO

•

DENTON

Ummer, Ayrin, MD • Urhoghide, Noyoze M., MD • Weddel, Paula, MD • Weier, Alan V., MD • Wolf, Jared A., MD • Zenarosa, Nestor R., MD •

HEMATOLOGY

FAMILY MEDICINE

Krause, John R., MD

Angel, Richard Jr., DO • Aten, Laurie A., MD • Ayaram, Shrimant K., MD Levy, Alfred E., MD • Mlcak, Mark S., MD • Ramesh, Vani, MD •

HOSPICE PALLIATIVE MEDICINE

•

HEMATOLOGYPATHOLOGY

Fine, Robert L., MD

•

•

INFECTIOUS DISEASE

GASTROENTEROLOGY Anderson, Paul K., MD • Bassel, Katrina M., MD • Bogus, Houston Jr., MD • Chan, Vincent, MD • Dasari, Vijaya M., MD • Oommen, Shibu G., MD • Scott-Winful, Terilyn R., MD • Shahidzadeh, Rassa, MD • Srungaram, Praveen R., MD • Van Dinter, Thomas G. Jr., MD •

GENERAL SURGERY Arnold, David T. Jr., MD • Burkart, Ryan D., MD • Charney, Franklin J., MD • Connaughton, Robert H., MD Kennard, Warrett, MD • Kilgore, Julie K., MD • Le, Lam D., MD • Lester, Stephen P., MD • Steckler, Robert M., MD •

Jain, Sharad K., MD • Olivares, Jairo R., MD •

•

Acharya, Ashish, MD • Akram, Javed M., MD • Ansari, Sofia T., MD • Arora, Rangolee S., MD • Baum, Sue E., MD • Berhe, Mezgebe G., MD • Bettacchi, Christopher J., MD • Davis, Steven G., MD • Hardy, Robert D., MD • Hobratsch, Lauren V., MD • Khair, Hani N., MD • Krishnan, Sujatha, MD • Kussman, Howard M., MD • Liao, Valerie L., MD • Martinez, Marcos, DO • Prabhakar, Meenakshi S., MD • Purkayastha, Tania, MD • Seriburi, Vimon, MD • Sloan, Louis M., MD • Spak, Cedric W., MD • Storey, Donald F., MD • Subramanian, Obulakshmipriya, MD • Tummala, Chaitanya V., MD •

GERIATRIC MEDICINE Haq, Mahenaaz, MD • Norman, Mary A., MD •

• PLANO & DENTON

67

MEDICAL STAFF INTERNAL MEDICINE Abbasi, Bushra, MD • Abid, Henia A., DO • Afzal, Atif, MD • Ali, Deeba N., MD • Allen, Henry, MD • Bakhtari, Ladan, MD • Bayya, Swathi R., MD • Benjamin, Bijas, MD • Boe, Ruth, MD • Chen, Richard C., MD • Ciborowski, Carl E., MD • Dar, Vaqar A., MD • Dinh, Marie T., MD • Duong, Trung, MD • Ekweani, Obiora M., MD • Farah, Nabeel W., MD • Fojt, James A., DO • Gowda, Champa R., MD • Gupta, Shilpa, DO • Harman, Bruce A., MD • Harvey, Tiffany M., MD • Hemani, Sana, DO • Holcomb, Donald, DO • Husain, Abiha S., DO • Jones, Bradley S., MD • Kazi, Ruchika, MD • Kennedy, Julie E., MD • Kim, Kevin Y., MD • Koduri, Padmavathi, MD • Kumar, Sumit, MD • Lahiri, Sayantani C., MD • Lee, David P., MD • Lone, Jamal Q., MD • Mao, Zhi, MD • Molen, Kyle D., MD • Moparty, Deepa R., MD • Muckatira, Bopanna, MD • Namburi, Swati, MD • Nassi, Shahryar S., MD • Nation-Howard, Brieanna, DO Noorudeen, Shafeeq, MD • Omar, Anees J., MD •

68

Parekh, Julie S., MD • Pudupakkam, Jay, MD • Raghu, Aarti, MD • Ramasahayam, Lakshmi, MD Ramirez, Kenda L., MD • Reddy, Samitha M., MD • Russell, Carl L., MD • Samsula, Aaron L., MD • Shie, Michael M., MD • Shipchandler, Abeezar T., MD Stack, Peter S., MD • Strawman, David A., MD • Studley, Jill L., MD • Sunderajan, Kirtana, MD • Tarjan, Tania, MD • Tang, Michael J., MD • Velazquez, Karen, MD • Yazdani, Rehan S., MD • Zimmer, Jennifer K., MD •

Gangasani, Aravind, MD • Gladden, Jeffrey R., MD • Gopal, Ambarish, MD • Gordon, Bruce M., DO • Gottlieb, Robert L., MD • Gunukula, Srinivas R., MD • Hameed, Irfan, MD • Harris, Ricky L., DO • Hecht, Phillip J., MD • Ho, Trieu Q., MD • Hollowell, John S., MD • Holper, Elizabeth, MD • Isaac, Michael G., MD • Jacob, Abraham, MD • Jaffrani, Waseem M., MD • Kalidindi, Vishnu V., MD • Kamili, Fayak S., MD • Karim, M. A., MD • Kazi, Farhana, MD • Kennedy, Patrick L., MD • Khan, Muhammad A., MD • Kindsvater, Steven M., MD • Klein, Mordecai N., MD • Korlakunta, Hema L., MD • Kosuri, Subba R., MD • Krock, Marc D., MD • Lawson, John William R., MD • Liao, Robert, MD • Maddukuri, Prasad V., MD • Makkena, Babu, MD • Malik, Salman N., MD • Mallick, Saleem H., MD • Manhas, Amit H., MD • Marshall, Winston S., MD • Meacham, Joseph A., MD • Moore, Larry C., MD • Morales, Philip A., MD • Nussbaumer, Samuel A., MD • Paranandi, Srinivas N., MD • Parikh, Biren, MD • Park, Robert C., MD • Parr, Norvin G. III, MD • Patel, Rikesh, MD • Paturu, Prasad V., MD •

•

•

INTERVENTIONAL CARDIOLOGY

•

Abo-Auda, Wael S., MD • Agarwal, Poonam G., MD • Aligeti, Venkata, MD • Ammar, Richard F., MD • Arora, Neeraj, MD • Bhargava, Sanjay, MD • Boehrer, James D., MD • Bowers, Bruce S., MD • Brown, David L., MD • Chemmalakuzhy, Jacob, MD • Cianci, Christopher B., DO • Cruz, Manuel W., MD • Dao, Timothy D., MD • Eichhorn, Eric J., MD • Engleman, David A., MD • Fazio, Gary P., MD • Feingold, Richard J., DO • Finkelstein, Jason S., MD • Frenkel, Peter A., MD • Fyfe, Alistair I., MD • Gan, Luisa Y., MD •

•

PLANO

•

DENTON

Peterman, Mark A., MD • Pettijohn, Trent L., MD • Pillay, Prem S., MD • Poliner, Lawrence R., MD • Potluri, Srinivasa P., MD • Prewitt, David W., MD • Ramanath, Vijay S., MD • Reddy, Gautam B., MD • Reddy, Srinivasa A., MD • Rosenthal, J E. Jr., MD • Routh, L K., MD • Santos, Raul A. Jr., MD • Sayfo, Sameh, MD • Scherer, David M., MD • Schwartz, David A., MD • Shah, Dhirendra L., MD • Shah, Rishin, MD • Sheth, Mukesh R., MD • Singh, Bhupinder, MD • Snyder, Richard W. II, MD • Solis, Rolando M., MD • Sontineni, Siva P., MD • Stewart, Bobby R., MD • Stoler, Robert C., MD • Stone, Sabrina, MD • Szerlip, Molly, MD • Theleman, Kevin P., MD • Varma, Jai, MD •

NEPHROLOGY Asghar, Arshad, MD • Beathard, Steven D., MD • Biedermann, Scott A., MD • Cespedes, Paul L., MD • Chebrolu, Srivasa B., MD • Chen, Jun, MD • Corpier, Cindy L., MD • Farkas, Robert A., MD • Gajanayaka, Ranil, MD • Garg, Nidhi, MD • George, Jessie, MD • Glowacki, Lori S., MD • Hartono, John R., MD •

• PLANO & DENTON

Hsu, Alice L., MD • Hussain, Mohammad F., MD • Jabbar, Samad A., MD • Jabbar, Wasey A., MD • Jagalur, Anjana S., MD • Jyothinagaram, Praveena, MD • Kaiser, Shaun, MD • Krishnamurthy, Gururaj, MD • Kumar, Surachit, MD • Landgarten, Michael J., MD • Makadia, Parin M., MD • Mapakshi, Nandana, MD • Margassery, Suresh K., MD • Mawla, Neghae, MD • Mehdi, Uzma F., MD • Mohmand, Hashim K., MD • Nadella, Rama, MD • Nguyen, Thai Q., MD • Pakkivenkata, Uma Bhimeshwara R., MD • Panesar, Atinder Pal S., MD • Patel, Tapan J., MD • Peri, Usha N., MD • Racheruvu, Mamatha, MD • Reyes, Hector M., MD • Rizwan, Syed A., MD • Rojas, George A., DO • Ruiz, Mario A., MD • Saghir, Syed S., MD • Saquib, Rehana, MD • Siddiqui, Nadeem A., MD • Smith, Matthew T., MD • Stephens, Gregory K., MD • Syed, Samaha, MD • Venkatesan, Jayanti, MD • Verma, Suneet, MD • Wall, Bruce R., MD • Wiederkehr, Michael R., MD • Yalamanchili, Venkata A., MD •

NEUROLOGICAL SURGERY Loyola, Walter X., MD • Turner, Michael S., MD •

NEUROLOGY El Moslimany, Halima, MD • Haq, Anwarul, MD • Hyson, Morton I., MD • Jenevein, Nolan B., MD • Khoury, Chaouki K., MD • Lastimosa, Augusto C., MD • Michaelson, Paul S., MD • Miller, Spencer O., MD • Mitchell, Thomas A., MD • Nosnik, Pedro, MD • Ramirez, Carmen T., MD • Simpkins, Nicole, MD • Tank, Vivek H., MD • Toler, Kathy A., MD • Vengrow, Michael I., MD •

ONCOLOGY Flippo, Korie L., MD • Gupta, Manish, MD • Kovoor, Philip A., MD • Melmed, Gavin M., MD • Reddy, Sashidhar N., MD • Stokoe, Christopher T., MD • Stone, Scott A., MD • Trillo, Gerardo H., MD • Younas, Ahmer, MD •

OTOLARYNGOLOGY Kapadia, Lav S., MD Lunde, Kevin C., MD

• •

PHYSICAL MEDICINE AND REHAB Hume, John W., MD

•

PLASTIC SURGERY Young, Patty K., MD

•

PODIATRIC SURGERY Brook, Joel W., DPM • Dauphinee, Damien M., DPM Northcutt, David R., DPM •

•

PODIATRY Bastawros, David S., DPM • Richey-Smith, Lesley R., DPM

•

PULMONARY DISEASE Curry, Matthew W., MD • Erwin, Gary E. Jr., MD • Harness-Brumley, Cayce L., MD Iyer, Sridhar K., MD • Lilly, Jeffrey C., MD • Memon, Abdul M., MD • Memon, Saima B., MD • Myers, David P., MD • Taylor, Jeff E., MD • Vaquera, Key A., MD •

•

RADIATION ONCOLOGY Boyd, Jessamy A., MD • Petrikas, James J., Sr., DO

Cheung, Edson H., MD • Cook, Allan O. Jr., MD • DiMaio, John M., MD • Edgerton, James R., MD • Gonzalez-Stawinski, Gonzalo V., MD • Harrington, Katherine B., MD • Hebeler, Robert F. Jr., MD • Henry, Albert C. III, MD • Hoang, Thomas T., MD • Hutcheson, Kelley A., MD • Jett, Gary K., MD • Lewis, Harry M., MD • Lima, Brian, MD • Lytle, Bruce W., MD • MacHannaford, Juan C., MD • Mack, Michael J., MD • Magee, Mitchell J., MD • Moore, David O., MD • Norcross, James F., MD • Ryan, William H. III, MD • Smith, Robert L. II, MD • Tauriainen, Mikko P., MD • Tran, Minh P., MD • Wallace, William E., DO • Wilcott, Robert J., MD •

UROLOGY

•

Allen, Mark L., MD • Benaim, Elie, MD • Fetner, Christopher D., MD • Hassell, Jeffrey S., MD • Holden, A M. Jr., MD • Kim, Nancy Y., MD • Lieman, Stephen J., MD • McBride, Dan G., MD • Mitchell, William C., MD • Mootha, Ravi K., MD • Moskowitz, Mitchell O., MD • Mulchin, William L., MD • Rogenes, Vince J., MD • Stringer, Jared D., MD • Tran, Anh-Hong H., MD •

SLEEP MEDICINE Farah, Nabeel W., MD • Thirumalai, Shanti, MD •

THORACIC SURGERY Acuff, Tea E., MD • Bowman, Richard T., MD • Brinkman, William T., MD • Cai, Tung H., MD • Chamogeorgakis, Themistokles, MD • Chang-Tung, Eric G., MD • Chappell, Vicky L., MD •

•

PLANO

•

DENTON

VASCULAR & INTERVENTIONAL RADIOLOGY Batra, Dev, MD • Pong, Edward M., MD • Roman, Jorge L. III, MD •

VASCULAR NEUROLOGY Graybeal, Dion, MD Mir, Osman, MD •

•

VASCULAR SURGERY Baig, Mirza S., MD • Baqai, Atif, MD • Chu, Tuan-Hung B., MD • Cruz, Carlos P., MD • Eidt, John F., MD • Gable, Dennis R., MD • Grimsley, Bradley R., MD • Hayhurst, James C., MD • Hohmann, Stephen E., MD • Kakish, Humam B., MD • Kedora, John C., MD • Ortega, Raul E., MD • Pearl, Gregory J., MD • Shutze, William P., MD • Smith, Bertram L. III, MD • Stephanian, Edic, MD • Vasquez, Javier, Jr., MD • Yau, Franklin S., MD •

• PLANO & DENTON

69

2015/2016 PUBLICATIONS 2016 2015 The American Association for Thoracic Surgery Consensus Guidelines: Ischemic mitral valve regurgitation.

American Association for Thoracic Surgery Ischemic Mitral Regurgitation Consensus Guidelines Writing Committee: Kron IL, Acker MA, Adams DH, Ailawadi G, Bolling SF, Hung JW, Lim DS, LaPar DJ, Mack MJ, O’Gara PT, Parides MK, Puskas JD. The Journal of Thoracic and Cardiovascular Surgery. April 2016.

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Levin GN, Bates ER, Mack MJ, et al. Journal of the American College of Cardiology. March 2016.

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/ American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/ SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/ AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ ACC Guideline for the Management of Patients With Non-ST-Elevation

70

Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. Levin GN, Bates ER, Mack MJ, et al. Circulation. March 2016.

Annual Outcomes with Transcatheter Valve Therapy: From the STS/ACC TVT Registry. Holmes DR Jr., Nishimura RA, Mack MJ, et al. Annals of Thoracic Surgery.

February 2016.

Aortic Regurgitation Caused by an Aberrant Mitral Chord Tethering the Anterior Mitral Leaflet to an Aortic Valve Cusp. Hebeler KR, Squiers JJ, Arsalan M, Baumgarten H, Moore DO, Ryan WH, Mack MJ, Grayburn P, DiMaio JM. The Annals of Thoracic Surgery. May 2016.

Atrial Fibrillation Is Associated With Increased Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement: Insights From the Placement of Aortic Transcatheter Valve (PARTNER) Trial.

Biviano AB, Nazif T, Dizon J, Garan H, Fleitman J, Hassan D, Kapadia S, Babaliaros V, Xu K, Parvataneni R, Rodes-Cabau J, Szeto WY, Fearon WF, Dvir D, Dewey T, Williams M, Mack MJ, Webb JG, Miller DC, Smith CR, Leon MB, Kodali S. Circulation: Cardiovascular Interventions. January 2016.

Autophagic flux in glioblastoma cells.

Yasui LS, Duran M, Andorf C, Kroc T, Owens K, Allen-Durdan K, Schuck A, Grayburn PA, Becker R. International Journal of Radiation Biology. March 2016.

Avoidance of Retrograde Type A Dissection During Intervention for Acute Complicated Type B Dissection. Gable DR, Shutze W. Vascular and Endovascular Challenges Update. 2016.

Causes of Death Following PCI Versus CABG in Complex CAD: 5-Year Follow-Up of SYNTAX. Milojevic M, Head SJ, Parasca CA, Serruys PW, Mohr FW, Morice MC, Mack MJ, Ståhle E, Feldman TE, Dawkins KD, Colombo A, Kappetein AP, Holmes DR Jr. Journal of the American College of Cardiology. January 2016.

Clinical Perspective-Early Feasibility Device Medical Studies in the United States: Time for More Than Regulatory Reform. Holmes DR Jr., Shuren J, Califf R, Zuckerman B, Abel D, Farb A, Leon M, Mack MJ. JACC: Cardiovascular Interventions. March 2016.

Coronary Artery Bypass Grafting Is Currently Underutilized. Arsalan M, Mack MJ. Circulation. March 2016.

Defining the clinical need and indications: who are the right patients for transcatheter mitral valve replacement?

Baumgarten H, Squiers JJ, Arsalan M, DiMaio JM, Mack MJ. The Journal of Cardiovascular Surgery. March 2016.

Does the Eyeball Test Have 20/20 Vision or Can We Do Better? Mack MJ, Holper EM. Journal of the American College of Cardiology. July 2016.

Engineering a Synthetic Anaerobic Respiration for Reduction of Xylose to Xylitol Using NADH Output of Glucose Catabolism by Escherichia Coli AI21.

Iverson A, Garza E, Manow R, Wang J, Gao Y, Grayburn PA, Zhou S. BMC Systems Biology. April 2016.

Epidemiology, Traditional and Novel Risk Factors in Coronary Artery Disease. Mack MJ, Gopal A. The Heart Failure Clinic. January 2016.

Excess Short-Term Mortality in Women After Isolated Coronary Artery Bypass Graft Surgery. Filardo G, Hamman BL, Pollock BD, da Graca B, Sass DM, Phan TK, Edgerton J, Prince SL, Ring WS. Open Heart.

March 2016.

Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights from the PREVENT IV Trial. Harskamp RE, Alexander JH, Mack MJ, et al. Circulation.

January 2016.

Gait Speed Predicts 30-Day Mortality Following Transcatheter Aortic Valve Replacement: Results From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry™. Alfredsson J, Stebbins A, Brennan JM, Matsouaka R, Afilalo J, Peterson ED, Vemulapalli S, Rumsfeld JS, Shahian D, Mack MJ, Alexander KP. Circulation. February 2016.

Here Today, Gone Tomorrow. Holmes DR Jr., Mack MJ. Journal of the American College of Cardiology. February 2016.

Initial Experience With Commercial Transcatheter Mitral Valve Repair in the United States. Sorajja P, Mack MJ, Vemulapalli S, Holmes DR Jr., Stebbins A, Kar S, Lim DS, Thourani V, McCarthy P, Kapadia S, Grayburn P, Pedersen WA, Ailawadi G. Journal of the American College of Cardiology. March 2016.

Just because you get on a scale doesn’t mean you lose weight: is Meetbaar Beter really measurably better? Mack MJ, Baumgarten H. European Journal Cardio-Thoracic Surgery. March 2016.

Late Breaking Trials of 2015 in Structural Heart Disease and Peripheral Artery Disease: Commentary Covering ACC, EuroPCR, SCAI, TCT, VIVA, ESC, and AHA. Armstrong EJ, Chhatriwalla AK, Szerlip M, Swaminathan RV, Patel RA. Catheterization and Cardiovascular Interventions. March 2016.

Midterm Results of Internal Iliac Artery Preservation Using the Sandwich Technique During Endovascular Aneurysm Repair. Shutze Sr. W, Kedora J, Hohmann S, Gable DR, Pearl G, Eidt JF. Journal of Vascular Surgery. 2016.

Mitral valve disease – current management and future challenges.

Nishimura RA, Vahanian A, Eleid MF, Mack MJ. Lancet. March 2016.

Multispectral and Photoplethysmography Optical Imaging Techniques Identify Important Tissue Characteristics in an Animal Model of Tangential Burn Excision. Thatcher JE, Li W, RodriguezVaqueiro Y, Squiers JJ, Mo W, Lu Y, Plant KD, Sellke E, King DR, Fan W, Martinez-Lorenzo JA, DiMaio JM. Journal of Burn Care and Rehabilitation. 2016.

Penetration, Completeness, and Representativeness of The Society of Thoracic Surgeons Adult Cardiac Surgery Database. Jacobs JP, Shahian DM, He X, O’Brien SM, Badhwar V, Cleveland JC Jr., Furnary AP, Magee MJ, Kurlansky PA, Rankin JS, Welke KF, Filardo G, Dokholyan RS, Peterson ED, Brennan JM, Han JM, McDonald D, Schmitz D, Edwards FH, Prager RL, Grover F. The Annals of Thoracic Surgery. January 2016.

Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, Granger CB, Lange RA, Mack MJ, Mauri L, Mehran R, Mukherjee D, Newby LK, O’Gara PT, Sabatine MS, Smith PK, Smith SC Jr. Circulation. March 2016.

Practice Gaps in the Care of Mitral Valve Regurgitation: Insights from the American College of Cardiology Mitral Regurgitation Gap Analysis and Advisory Panel. Wang A, Grayburn PA, Foster JA, McCulloch ML, Badhwar V, Gammie JS, Costa SP, Benitez RM, Rinaldi MJ, Thourani VH, Martin RP. American Heart Journal.

February 2016.

Preventative Medicine: The Next Revolution in the Treatment of Aortic Stenosis. Squiers JJ, Harrington KB, Arsalan M, DiMaio JM. The Journal of Thoracic and Cardiovascular Surgery. 2016.

Prognostic Usefulness of Acute Kidney Injury After Transcatheter Aortic Valve Replacement. Arsalan M, Squiers JJ, Farkas R, Worley C, Herbert M, Stewart W, Brinkman WT, Ungchusri E, Brown DL, Mack MJ, Holper EM. American Journal of Cardiology. April 2016.

Rate Control Versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery.

Gillinov AM, Bagiella E, Moskowitz AJ, Raiten JM, Groh MA, Bowdish ME, Ailawadi G, Kirkwood KA, Perrault LP, Parides MK, Smith RL, Kern JA, Dussault G, Hackmann AE, Jeffries NO, Miller MA, Taddei-Peters WC, Rose EA, Weisel RD, Williams DL, Mangusan RF, Argenziano M, Moquete EG, O’Sullivan KL, Pellerin M, Shah KJ, Gammie JS, Mayer ML, Voisine P, Gelijns AC, O’Gara PT, Mack MJ; CTSN. The New England Journal of Medicine. April 2016.

Results of Endovascular Repair of Iliac Artery Aneurysms in the GREAT Registry. Shutze Sr. W, Pearl G, Gable DR, Hohmann S, Kedora J, Eidt JF, Smith B. Journal of Vascular Surgery. 2016.

Results of the Nellix System Investigational Device Exemption Pivotal Trial for Endovascular Aneurysm Sealing. Carpenter JP, Cuff R, Buckley C, Healey C, Hussain S, Reijnen MM, Trani J, Böckler D, Vasquez J. Nellix Investigators. Journal of Vascular Surgery.

January 2016.

Risk Assessment in TAVR: Does the Eyeball Test Have 20/20 Vision or Can We Do Better? Mack MJ, Holper EM. Journal of the American College of Cardiology. 2016.

Sex Differences in Outcomes Following Percutaneous Coronary Intervention According to Age. Epps KC, Holper EM, Selzer F, Vlachos HA, Gualano SK, Abbott JD, Jacobs AK, Marroquin OC, Naidu SS, Groeneveld PW, Wilensky RL. Circulation: Cardiovascular Quality and Outcomes.

January 2016.

Sex-Specific Differences at Presentation and Outcomes Among Patients Undergoing Transcatheter Aortic Valve Replacement: A Cohort Study. Kodali S, Williams MR, Doshi D, Hahn RT, Humphries KH, Nkomo VT, Cohen DJ, Douglas PS, Mack MJ, Xu K, Svensson L, Thourani VH, Tuzcu EM, Weissman NJ, Leon M, Kirtane AJ. Annals of Internal Medicine. March 2016.

Sex Differences in Mitral Regurgitation Before and After Mitral Valve Surgery.

Grayburn PA. JACC: Cardiovascular Imaging. April 2016.

Shedding More Light on Valve Thrombosis After Transcatheter Aortic Valve Replacement. Mack MJ, Douglas PS, Holmes DR. Journal of the American College of Cardiology. February 2016.

Should Transcatheter Aortic Valve Replacement Be Performed in Nonagenarians?: Insights From the STS/ ACC TVT Registry. Arsalan M, Szerlip M, Vemulapalli S, Holper EM, Arnold SV, Li Z, DiMaio MJ, Rumsfeld JS, Brown DL, Mack MJ. Journal of the American College of Cardiology. March 2016.

SR-XRD in situ monitoring of copper-IUD corrosion in simulated uterine fluid using a portable spectroelectrochemical cell. Grayburn PA, Dowsett MG, Sabbe PJ, Wermeille D, Anjos JA, Flexer V, De Keersmaecker M, Wildermeersch D, Adriaens A. Bioelectrochemistry. August 2016.

Successful MitraClip® implantation after angioplasty of a chronic inferior vena cava filter thrombosis. Barbin C, Grayburn PA, Choi J. Catheterization and Cardiovascular Interventions. June 2016.

71

PUBLICATIONS Surgical Versus Percutaneous Femoral Access for Delivery of Large-Bore Cardiovascular Devices (from the PARTNER Trial). McCabe JM, Huang PH, Cohen DJ, Blackstone EH, Welt FG, Davidson MJ, Kaneko T, Eng MH, Allen KB, Xu K, Lowry AM, Lei Y, Rajeswaran J, Brown DL, Mack MJ, Webb JG, Smith CR, Leon MB, Eisenhauer AC. American Journal of Cardiology. May 2016.

The effect of wavelength on endothermal heat-induced thrombosis incidence after endovenous laser ablation. Shutze WP, Kane K, Fisher T, Doud Y, Lassiter G, Leuking R, Nguyen E, Shutze WP Jr. Journal of Vascular Surgery: Venous and Lymphatic Disorders. 2016.

The Future of Transcatheter Aortic Valve Implantation. Hamm CW, Arsalan M, Mack MJ. European Heart Journal.

March 2016.

The Harder One Looks, The More One Finds. Mack MJ. The Journal of Thoracic and Cardiovascular Surgery. March 2016.

The Impact of Aneurysm Morphology and Anatomical Characteristics on Long Term Survival after EVAR. Mahajan A, Barber M, Cumbie T, Filardo G, Shutze WP, Sass DM, Shutze Sr. W. Annals of Vascular Surgery. May 2016.

The Outcomes of Transcatheter Aortic Valve Replacement in a Cohort of Patients with End-Stage Renal Disease.

Szerlip M, Kim RJ, Adeniyi T, Thourani V, Babaliaros V, Bavaria J, Herrmann HC, Anwaruddin S, Makkar R, Chakravarty T, Rovin J, Creighton D, Miller DC, Baio K, 72

Walsh E, Katinic J, Letterer R, Trautman L, Herbert M, Farkas R, Rudolph J, Brown DL, Holper EM, Mack MJ. Catheterization and Cardiovascular Interventions. March 2016.

The Society of Thoracic Surgeons/ American College of Cardiology Transcatheter Valve Therapy Registry.

Alfredsson J, Stebbins A, Mack MJ, et al.

Circulation. April 2016.

Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Intermediate-risk patients: a propensity score analysis. Thourani VH, Kodali S, Mack MJ, et al. Lancet. April 2016.

Transcatheter Mitral Valve Therapy: The Event Horizon. Badhwar V, Thourani WH, Mack MJ, et al. The Journal of Thoracic and Cardiovascular Surgery. April 2016.

Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, Thourani VH, Tuzcu EM, Miller DC, Herrmann HC, Doshi D, Cohen DJ, Pichard AD, Kapadia S, Dewey T, Babaliaros V, Szeto WY, Williams MR, Kereiakes D, Zajarias A, Greason KL, Whisenant BK, Hodson RW, Moses JW, Trento A, Brown DL, Fearon WF, Pibarot P, Hahn RT, Jaber WA, Anderson WN, Alu MC, Webb JG; PARTNER Investigators. New England Journal of Medicine. April 2016.

Transient Ischemic Attack Caused by Contrast Echocardiography in a Patient with Platypnea-orthodeoxia. Main ML, Feinstein SB, Feinstein LM, Grayburn PA, Wilson SR. Echocardiography. January 2016.

Trends and comparison of female first authorship in high impact medical journals: observational study (19942014). Filardo G, da Graca B, Sass DM, Pollock BD, Smith EB, Martinez MA. The BMJ. March 2016.

Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation. Goldstein D, Moskowitz AJ, Gelijns AC, Ailawadi G, Parides MK, Perrault LP, Hung JW, Voisine P, Dagenais F, Gillinov AM, Thourani V, Argenziano M, Gammie JS, Mack MJ, Demers P, Atluri P, Rose EA, O’Sullivan K, Williams DL, Bagiella E, Michler RE, Weisel RD, Miller MA, Geller NL, Taddei-Peters WC, Smith PK, Moquete E, Overbey JR, Kron IL, O’Gara PT, Acker MA; CTSN. The New England Journal of Medicine. January 2016.

Using Discrete Event Simulation to Model the Economic Value of Shorter Procedure Times on EP Lab Efficiency in the VALUE PVI Study. Kowalski M, DeVille JB, Svinarich JT, Dan D, Wickliffe A, Kantipudi C, Foell JD, Filardo G, Holbrook R, Baker J, Baydoun H, Jenkins M, Chang-Sing P. Journal of Invasive Cardiology. March 2016.

Vdrive Evaluation of Remote Steering and Testing in Lasso Electrophysiology Procedures Study: The VERSATILE Study in Atrial Fibrillation Ablation.

Nölker G, Schwagten B, DeVille JB, Burkhardt JD, Horton RP, Sha Q, Tomassoni G. Journal of Cardiovascular Electrophysiology. March 2016.

2015 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomized controlled trial. Mack MJ, Brown DL., Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, Webb JG, Douglas PS, Anderson WN, Blackstone EH, Kodali SK, Makkar RR, Fontana. Lancet. July 2015.

50th Anniversary Landmark Commentary on Tribble CG, Killinger WA Jr., Harman PK, Crosby IK, Nolan SP, Kron IL. Anterolateral thoracotomy as an alternative to repeat median sternotomy for replacement of the mitral valve.

Ann Thorac Surg 1987;43:380-2. Mack MJ. The Annals of Thoracic Surgery.

December 2015.

A call for evidence-based approach to the Heart Team for patients with severe aortic stenosis. Coylewright M, Mack MJ, Holmes DR Jr., O’Gara PT. Journal of the American College of Cardiology. April 2015.

A hybrid repair of a superior mesenteric artery pseudoaneurysm using open mesenteric bypass and endovascular exclusion. Cumbie TA, Kedora JC, Pearl GJ, Shutze WP. Baylor University Medical Center Proceedings. 2015.

A Nationwide Survey on Perception, Experience, and Expectations of Hybrid Coronary Revascularization Among TopRanked US Hospitals. Harskamp RE, Halkos ME, Xian Y, Szerlip MA, Poston RS, Mick SL, Lopes RD, Tijssen JG, de Winter RJ, Peterson ED. American Heart Journal. April 2015.

A porcine model for aortic valve insufficiency: If pigs could fly, they would teach surgeons to treat AI. Squiers JJ, Brinkman WT, Arsalan M, DiMaio JM. The Journal of Thoracic Cardiovascular Surgery. September 2015.

A Randomized Evaluation of the SAPIEN XT Transcatheter Heart Valve System in Patients with Aortic Stenosis Who Are Not Candidates for Surgery. Webb JG, Doshi D, Mack MJ, Makkar R, Smith CR, Pichard AD, Kodali S, Kapadia S, Miller DC, Babaliaros V, Thourani V, Herrmann HC, Bodenhamer M, Whisenant BK, Ramee S, Maniar H Jr., Kereiakes D, Xu K, Jaber WA, Menon V, Tuzcu EM, Wood D, Svensson LG, Leon MB. JACC: Cardiovascular Interventions. December 2015.

Acute Kidney Injury After Carotid Artery Stenting. McCullough PA, Young A, Shutze WP. JACC Cardiovascular Imaging.

September 2015.

An analysis of the blood pressure and safety outcomes to renal denervation in African Americans and Non-African Americans in the SYMPLICITY HTN-3 trial. Flack JM, Bhatt DL, Kandzari DE, Brown D, Brar S, Choi JW, D’Agostino R, East C, Katzen BT, Lee L, Leon MB, Mauri L, O’Neill WW, Oparil S, Rocha-Singh K, Townsend RR, Bakris G; SYMPLICITY HTN-3 Investigators. Journal of the American Society of Hypertension. October 2015.

Annual Outcomes With Transcatheter Valve Therapy: From the STS/ACC TVT Registry. Holmes DR Jr., Nishimura RA, Grover FL, Brindis RG, Carroll JD, Edwards FH, Peterson ED, Rumsfeld JS, Shahian DM, Thourani VH, Tuzcu EM, Vemulapalli S,

Hewitt K, Michaels J, Fitzgerald S, Mack MJ; STS/ACC TVT Registry. Journal of the American College of Cardiology.

December 2015.

Aortic root rupture after TAVR in two renal transplant patients on chronic immunosuppressant therapy.

Holper EM, Kim RJ, Brooks A, Mack MJ. Catheterization and Cardiovascular Interventions. April 2015.

Appropriate patient selection or health care rationing? Lessons from surgical aortic valve replacement in the Placement of Aortic Transcatheter Valves I trial. Szeto WY, Svensson LG, Rajeswaran J, Ehrlinger J, Suri RM, Smith CR, Mack MJ, Miller DC, McCarthy PM, Bavaria JE, Cohn LH, Corso PJ, Guyton RA, Thourani VH, Lytle BW, Williams MR, Webb JG, Kapadia S, Tuzcu EM, Cohen DJ, Schaff HV, Leon MB, Blackstone EH; Placement of Aortic Transcatheter Valves Trial Investigators. The Journal of Thoracic Cardiovascular Surgery.

2015.

Association of Patient-Reported Health Status With Long-Term Mortality After Transcatheter Aortic Valve Replacement: Report From the STS/ACC TVT Registry.

Arnold SV, Spertus JA, Vemulapalli S, Dai D, O’Brien SM, Baron SJ, Kirtane AJ, Mack MJ, Green P, Reynolds MR, Rumsfeld JS, Cohen DJ. Circulation: Cardiovascular Interventions. December 2015.

Catheter-based or surgical repair of the highest risk secondary mitral regurgitation patients. Arsalan M, Squiers JJ, DiMaio JM, Mack MJ. The Annals of Cardiothoracic Surgery. May 2015.

Cerebral protection during deep hypothermic circulatory arrest: Can a molecular approach via microRNA inhibition improve on a millennia-old strategy? Squiers JJ, Arsalan M, Lima B, DiMaio JM. The Journal of Thoracic Cardiovascular Surgery. September 2015.

Clinical and morphologic features of acute, subacute and chronic cor pulmonale (pulmonary heart disease).

Roberts WC, Shafii AE, Grayburn PA, Ko JM, Weissenborn MR, Rosenblatt RL, Guileyardo JM. The American Journal of Cardiology.

March 2015.

Clinical outcomes at 1 year following transcatheter aortic valve replacement.

Holmes DR Jr., Brennan JM, Rumsfeld JS, Dai D, O’Brien SM, Vemulapalli S, Edwards FH, Carroll J, Shahian D, Grover F, Tuzcu EM, Peterson ED, Brindis RG, Mack MJ; STS/ACC TVT Registry. The Journal of the American Medical Association. Journal of the American College of Cardiology.

March 2015.

Can we make stroke during cardiac surgery a never event? Mack MJ. The Journal of Thoracic Cardiovascular Surgery. April 2015.

73

PUBLICATIONS Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 1: Clinical Trial Design Principles: A Consensus Document From the Mitral Valve Academic Research Consortium.

Stone GW, Vahanian AS, Adams DH, Abraham WT, Borer JS, Bax JJ, Schofer J, Cutlip DE, Krucoff MW, Blackstone EH, Généreux P, Mack MJ, Siegel RJ, Grayburn PA, Enriquez-Sarano M, Lancellotti P, Filippatos G, Kappetein AP; Mitral Valve Academic Research Consortium (MVARC). Journal of the American College of Cardiology. July 2015.

Community Health Fair with Follow-up.

Squiers JJ, Purmal C, Silver M, Gimpel N. Medical Education. May 2015.

Comparison of Transesophageal and Transthoracic Echocardiographic Measurements of Mechanism and Severity of Mitral Regurgitation in Ischemic Cardiomyopathy (from the Surgical Treatment of Ischemic Heart Failure Trial). Grayburn PA, She L, Roberts BJ, Golba KS, Mokrzycki K, Drozdz J, Cherniavsky A, Przybylski R, Wrobel K, Asch FM, Holly TA, Haddad H, Yii M, Maurer G, Kron I, Schaff H, Velazquez EJ, Oh JK. Journal of the American College of Cardiology. September 2015.

Contemporary Real-World Outcomes of Surgical Aortic Valve Replacement in 141,905 Low-Risk, Intermediate-Risk, and High-Risk Patients. Thourani VH, Suri RM, Gunter RL, Sheng S, O’Brien SM, Ailawadi G, Szeto WY, Dewey TM, Guyton RA, Bavaria JE, Babaliaros V, Gammie JS, Svensson L, Williams M, Badhwar V, Mack MJ. The Annals of Thoracic Surgery.

January 2015.

74

Coronary artery bypass grafting in patients with diabetes: The weight is on us. Arsalan M, Mack MJ. The Journal of Thoracic Cardiovascular Surgery.

August 2015.

Covered stent grafts in the SFA are still the endovascular champion in long lesions. Gable DR. Vasc Spec. 2015.

Differences in baseline characteristics, practice patterns and clinical outcomes in contemporary coronary artery bypass grafting in the United States and Europe: insights from the SYNTAX randomized trial and registry. Head SJ, Parasca CA, Mack MJ, Mohr FW, Morice MC, Holmes DR Jr., Feldman TE, Dawkins KD, Colombo A, Serruys PW, Kappetein AP; SYNTAX Investigators. European Journal of Cardio-Thoracic Surgery. April 2015.

Durability of devices: long-term results and clinical outcomes. Arsalan M, Mack MJ. European Heart Journal. September 2015.

Echocardiographic imaging of procedural complications during balloon-expandable transcatheter aortic valve replacement.

Hahn RT, Kodali S, Tuzcu EM, Leon MB, Kapadia S, Gopal D, Lerakis S, Lindman BR, Wang Z, Webb J, Thourani VH, Douglas PS. JACC Cardiovascular Imaging. March 2015.

Effect of gender and race on operative mortality after isolated coronary artery bypass grafting. Pollock B, Hamman BL, Sass DM, da Graca B, Grayburn PA, Filardo G. The American Journal of Cardiology.

March 2015.

Effect of tricuspid regurgitation and the right heart on survival after transcatheter aortic valve replacement: insights from the Placement of Aortic Transcatheter Valves II inoperable cohort. Lindman BR, Maniar HS, Jaber WA, Lerakis S, Mack MJ, Suri RM, Thourani VH, Babaliaros V, Kereiakes DJ, Whisenant B, Miller DC, Tuzcu EM, Svensson LG, Xu K, Doshi D, Leon MB, Zajarias A. Circulation: Cardiovascular Interventions. April 2015.

Effectiveness of exclusion of a persistent sciatic artery aneurysm with an Amplatzer plug. Allen L, Hohmann SE, Shutze WP. Baylor University Medical Center Proceedings, The peer-reviewed journal of Baylor Scott & White Health. 2015.

Hemodynamic outcomes of transcatheter aortic valve replacement and medical management in severe, inoperable aortic stenosis: a longitudinal echocardiographic study of cohort B of the PARTNER trial. Douglas PS, Hahn RT, Pibarot P, Weissman NJ, Stewart WJ, Xu K, Wang Z, Lerakis S, Siegel R, Thompson C, Gopal D, Keane MG, Svensson LG, Tuzcu EM, Smith CR, Leon MB. Journal of the American Society of Echocardiography. February 2015.

Iliac Artery Stenosis Complicating Iliac Vein Stenting in a Patient with a History of Radiation and Cancer: Case Report and Literature Review. Busken C, Grimsley B, Shutze WP. Annals of Vascular Surgery. 2015.

Evaluation of renal function before and after percutaneous mitral valve repair.

Wang A, Sangli C, Lim S, Ailawadi G, Kar S, Herrmann HC, Grayburn P, Foster E, Weissman NJ, Glower D, Feldman T. Circulation: Cardiovascular Interventions. January 2015.

Improved long-term survival for diabetic patients with surgical versus interventional revascularization.

Kurlansky P, Herbert M, Prince S, Mack MJ. The Annals of Thoracic Surgery. April 2015.

Experience with Chest Wall Arteriovenous Grafts in Hemodialysis Patients. Liechty J, Fisher T, Davis W, Oglesby W, Bennett M, Shutze WP. Annals of Vascular Surgery.

May 2015.

In vivo targeted delivery of ANGPTL8 gene for beta cell regeneration in rats.

Chen J, Chen S, Huang P, Meng XL, Clayton S, Shen JS, Grayburn PA. Diabetologia.

May 2015.

Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights from the PREVENT IV Trial. Harskamp RE, Alexander JH, Ferguson TB Jr., Hager R, Mack MJ, Englum B, Wojdyla D, Schulte PJ, Kouchoukos NT, de Winter RJ, Gibson CM, Peterson ED, Harrington RA, Smith PK, Lopes RD. Circulation. December 2015.

Insights from the early experience of the Society of Thoracic Surgeons/ American College of Cardiology Transcatheter Valve Therapy Registry.

Rumsfeld JS, Holmes DR Jr., Stough WG, Edwards FH, Jacques LB, Mack MJ. JACC Cardiovascular Imaging. March 2015.

ISMICS Consensus Conference and Statements of Randomized Controlled Trials of Off-Pump Versus Conventional Coronary Artery Bypass Surgery. Puskas JD, Martin J, Cheng DC, Benussi S, Bonatti JO, Diegeler A, Ferdinand FD, Kieser TM, Lamy A, Mack MJ, Patel NC, Ruel M, Sabik JF 3rd, Yanagawa B, Zamvar V. Innovations (Phila). July 2015.

Learning curves for transfemoral transcatheter aortic valve replacement in the PARTNER-I trial: Success and safety. Mack MJ, et al. Minha S, Waksman R, Satler LP, Torguson R, Alli O, Rihal CS, Mack M, Svensson LG, Rajeswaran J, Blackstone EH, Tuzcu EM, Thourani VH, Makkar R, Ehrlinger J, Lowry AM, Suri RM, Greason KL, Leon MB, Holmes DR, Pichard AD. Catheterization and Cardiovascular Interventions. October 2015.

Learning curves for transfemoral transcatheter aortic valve replacement in the PARTNER-I trial: Technical performance. Alli O, Rihal CS, Suri RM, Greason KL, Waksman R, Minha S, Torguson R, Pichard AD, Mack MJ, Svensson LG, Rajeswaran J, Lowry AM, Ehrlinger J, Tuzcu EM, Thourani VH, Makkar R, Blackstone EH, Leon MB, Holmes D. Catheterization & Cardiovascular Interventions. April 2015.

Learning curves for transfemoral transcatheter aortic valve replacement in the PARTNER-I trial: Technical performance. Green P, Arnold SV, Cohen DJ, Kirtane AJ, Kodali SK, Brown DL, Rihal CS, Xu K, Lei Y, Hawkey MC, Kim RJ, Alu MC, Leon MB, Mack MJ. The American Journal of Cardiology. August 2015.

Mini-extracorporeal Circulation and Off-pump Techniques Associated with Less Inflammatory Gene Expression as Compared to On-pump in the 24-hour Postoperative Window Following Coronary Artery Bypass Grafting.

Brinkman WT, Squiers JJ, Arsalan M, Smith RL, Mack MJ, DiMaio JM. The Journal of Thoracic Cardiovascular Surgery.

December 2015.

Mitral Annulus Calcification. Abramowitz Y, Jilaihawi H, Chakravarty T, Mack MJ, Makkar RR. Journal of the American College of Cardiology. October 2015.

Moore’s Law: Apples and Oranges.

Holmes DR Jr., Mack MJ. JACC: Cardiovascular Interventions. November 2015.

Multimodality Imaging in the Context of Transcatheter Mitral Valve Replacement: Establishing Consensus Among Modalities and Disciplines. Blanke P, Naoum C, Webb J, Dvir D, Hahn RT, Grayburn PA, Moss RR, Reisman M, Piazza N, Leipsic J. JACC: Cardiovascular Imaging. October 2015.

Myocardial regeneration in adriamycin cardiomyopathy by nuclear expression of GLP1 using ultrasound targeted microbubble destruction. Chen S, Chen J, Huang P, Meng XL, Clayton S, Shen JS, Grayburn PA. Biochemical and Biophysical Research Communications. March 2015.

Noncontrast 3D CMR imaging for aortic valve annulus sizing in TAVR. Gopal A, Grayburn PA, Chacon I, Kim R, Montenegro D, Phan T, Rudolph J, Filardo G, Mack MJ, Gopalakrishnan D. JACC: Cardiovascular Imaging. March 2015.

Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up.

Iqbal J, Zhang YJ, Holmes DR, Morice MC, Mack MJ, Kappetein AP, Feldman T, Stahle E, Escaned J, Banning AP, Gunn JP, Colombo A, Steyerberg EW, Mohr FW, Serruys PW. Circulation. April 2015.

Outcomes in Nonagenarians Undergoing Transcatheter Aortic Valve Replacement in the PARTNER-I Trial. RA, Thourani VH, Lytle BW, Williams MR, Webb JG, Kapadia S, Tuzcu EM, Cohen DJ, Schaff HV, Leon MB, Blackstone EH; Placement of Aortic Transcatheter Valves Trial Investigators.

Mack, MJ. The Annals of Thoracic Surgery.

September 2015.

Outcomes of inoperable symptomatic aortic stenosis patients not undergoing aortic valve replacement: insight into the impact of balloon aortic valvuloplasty from the PARTNER trial (Placement of AoRtic TraNscathetER Valve trial).

Kapadia S, Stewart WJ, Anderson WN, Babaliaros V, Feldman T, Cohen DJ, Douglas PS, Makkar RR, Svensson LG, Webb JG, Wong SC, Brown DL, Miller DC, Moses JW, Smith CR, Leon MB, Tuzcu EM. JACC: Cardiovascular Interventions. February 2015.

Outcomes of Thoracic Endovascular Aortic Repair in Acute Type B Dissection: Results from the Valiant United States Investigational Device Exemption Study. Bavaria JE, Brinkman WT, Hughes GC, Khoynezhad A, Szeto WY, Azizzadeh A, Lee WA, White RA. The Annals of Thoracic Surgery. September 2015.

Outcomes of Patients With Severe Chronic Lung Disease Who Are Undergoing Transcatheter Aortic Valve Replacement. Suri RM, Gulack BC, Brennan JM, Thourani VH, Dai D, Zajarias A, Greason KL, Vassileva CM, Mathew V, Nkomo VT, Mack MJ, Rihal CS, Svensson LG, Nishimura RA, O’Gara PT, Holmes DR Jr. The Annals of Thoracic Surgery.

December 2015.

Outcomes of Treatment of Nonagenarians with Severe Aortic Stenosis. Szerlip M, Herbert MA, Akram S, Worley C, Kim RJ, Prince BA, Harrington KB, Mack MJ, Holper EM. The Annals of Thoracic Surgery. May 2015.

Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards SAPIEN valve in the PARTNER trial: characterizing patients and impact on outcomes.

Kodali S, Pibarot P, Douglas PS, Williams M, Xu K, Thourani V, Rihal CS, Zajarias A, Doshi D, Davidson M, Tuzcu EM, Stewart W, Weissman NJ, Svensson L, Greason K, Maniar H, Mack MJ, Anwaruddin S, Leon MB, Hahn RT. European Heart Journal.

February 2015.

75

PUBLICATIONS Perioperative Outcomes, Transfusion Requirements, and Inflammatory Response After Coronary Artery Bypass Grafting With Off-Pump, Mini-Extracorporeal, and On-Pump Circulation Techniques. Brinkman WT, Squiers JJ, Filardo G, Arsalan M, Smith RL, Moore D, Mack MJ, DiMaio JM. Journal of Investigative Medicine.

December 2015.

Porcelain aorta: a comprehensive review. Abramowitz Y, Jilaihawi H, Chakravarty T, Mack MJ, Makkar RR. Circulation. March 2015.

Predicting recurrent mitral regurgitation after mitral valve repair for severe ischemic mitral regurgitation. Kron IL, Hung J, Overbey JR, Bouchard D, Gelijns AC, Moskowitz AJ, Voisine P, O’Gara PT, Argenziano M, Michler RE, Gillinov M, Puskas JD, Gammie JS, Mack MJ, Smith PK, Sai-Sudhakar C, Gardner TJ, Ailawadi G, Zeng X, O’Sullivan K, Parides MK, Swayze R, Thourani V, Rose EA, Perrault LP, Acker MA; CTSN Investigators. The Journal of Thoracic Cardiovascular Surgery. March 2015.

Predictors and Clinical Outcomes of Permanent Pacemaker Implantation after Transcatheter Aortic Valve Replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) Trial and Registry. Nazif TM, Dizon JM, Hahn RT, Xu K, Babaliaros V, Douglas PS, El-Chami MF, Herrmann HC, Mack MJ, Makkar RR, Miller DC, Pichard A, Tuzcu EM, Szeto WY, Webb JG, Moses JW, Smith CR, Williams MR, Leon MB, Kodali SK; PARTNER Publications Office. JACC: Cardiovascular Interventions. January 2015.

76

Preimplantation valvuloplasty in transcatheter aortic valve replacement: To BAV or not to BAV? Arsalan M, Squiers JJ, Walther T. The Journal of Thoracic Cardiovascular Surgery.

November 2015.

Prognostic value of serial B-type natriuretic peptide measurement in transcatheter aortic valve replacement (from the PARTNER Trial). O’Neill BP, Guerrero M, Thourani VH, Kodali S, Heldman A, Williams M, Xu K, Pichard A, Mack MJ, Babaliaros V, Herrmann HC, Webb J, Douglas PS, Leon MB, O’Neill WW. The American Journal of Cardiology. May 2015.

Propensity-Matched Comparisons of Clinical Outcomes After Transapical or Transfemoral Transcatheter Aortic Valve Replacement: A Placement of Aortic Transcatheter Valves (PARTNER)-I Trial Substudy. Blackstone EH, Suri RM, Rajeswaran J, Babaliaros V, Douglas PS, Fearon WF, Miller DC, Hahn RT, Kapadia S, Kirtane AJ, Kodali SK, Mack MJ, Szeto WY, Thourani VH, Tuzcu EM, Williams MR, Akin JJ, Leon MB, Svensson LG. Circulation. June 2015.

Quantifying regional left ventricular contractile function: Leave it to the machines? Squiers JJ, Arsalan M, Thatcher JE, DiMaio JM. The Journal of Thoracic Cardiovascular Surgery. July 2015.

Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation: 5-Year Results of EVEREST II. Feldman T, Kar S, Elmariah S, Smart SC, Trento A, Siegel RJ, Apruzzese P, Fail P, Rinaldi MJ, Smalling RW, Hermiller JB, Heimansohn D, Gray WA, Grayburn PA,

Mack MJ, Lim DS, Ailawadi G, Herrmann HC, Acker MA, Silvestry FE, Foster E, Wang A, Glower DD, Mauri L; EVEREST II Investigators. Journal of the American College of Cardiology. December 2015.

Relation of Frailty to Outcomes After Transcatheter Aortic Valve Replacement (from the PARTNER Trial). Green P, Arnold SV, Cohen DJ, Kirtane AJ, Kodali SK, Brown DL, Rihal CS, Xu K, Lei Y, Hawkey MC, Kim RJ, Alu MC, Leon MB, Mack MJ. American Journal of Cardiology. July 2015.

Reply: Secondary Mitral Regurgitation.

Asgar AW, Mack MJ, Stone GW. Journal of the American College of Cardiology.

October 2015.

Reply: When to Call It Severe Mitral Regurgitation? Grayburn PA, Carabello B, Hung JW, Gillam LD, Liang D, Mack MJ, McCarthy PM, Miller DC, Trento A, Siegel RJ. Journal of the American College of Cardiology. July 2015.

Response to Letter Regarding Article, “Long-Term Outcomes of Inoperable Patients With Aortic Stenosis Randomly Assigned to Transcatheter Aortic Valve Replacement or Standard Therapy.”

Kapadia SR, Tuzcu EM, Makkar RR, Svensson LG, Agarwal S, Kodali S, Fontana GP, Webb JG, Mack MJ, Thourani VH, Babaliaros VC, Herrmann HC, Szeto WY, Pichard A, Williams MR, Anderson WN, Akin JJ, Miller DC, Smith CR, Leon MB. Circulation. August 2015.

Response to Letters Regarding Article, “Saphenous Vein Graft Failure After Coronary Artery Bypass Surgery: Insights from PREVENT IV.” Hess CN, Lopes RD, Gibson CM, Hager R, Wojdyla DM, Englum BR, Mack MJ, Kouchoukos NT, Peterson ED, Alexander JH. Circulation.

July 2015.

Risk stratification in patients with pulmonary hypertension undergoing transcatheter aortic valve replacement.

Lindman BR, Zajarias A, Maniar HS, Miller DC, Suri RM, Arnold SV, Webb J, Svensson LG, Kodali S, Xu K, Ayele GM, Lin F, Wong SC, Babaliaros V, Thourani VH, Douglas PS, Lim S, Leon MB, Mack MJ. Heart. October 2015.

SCAI/AATS/ACC/STS Operator and Institutional Requirements for Transcatheter Valve Repair and Replacement, Part III: Pulmonic Valve.

Hijazi ZM, Ruiz CE, Zahn E, Ringel R, Aldea GS, Bacha EA, Bavaria J, Bolman RM, Cameron DE, Dean LS, Feldman T, Fullerton D, Horlick E, Mack MJ, Miller DC, Moon MR, Mukherjee D, Trento A, Tommaso CL; Society for Cardiovascular Angiography and Interventions; American Association for Thoracic Surgery; American College of Cardiology; Society of Thoracic Surgeons.

The Annals of Thoracic Surgery. 2015. The Journal of Thoracic Cardiovascular Surgery.

2015. Journal of the American College of Cardiology. 2015. Catheterization & Cardiovascular Interventions. May 2015.

Secondary Mitral Regurgitation in Heart Failure: Pathophysiology, Prognosis, and Therapeutic Considerations. Asgar AW, Mack MJ, Stone GW. Journal of the American College of Cardiology.

March 2015.

Smoking is Associated with Adverse Clinical Outcomes in Patients Undergoing Revascularization with PCI or CABG: the SYNTAX Trial at 5-year Follow-Up. Zhang YJ, Iqbal J, van Klaveren D, Campos CM, Holmes DR, Kappetein AP, Morice MC, Banning AP, Grech ED, Bourantas CV, Onuma Y, Garcia-Garcia HM, Mack MJ, Colombo A, Mohr FW, Steyerberg EW, Serruys PW. Journal of the American College of Cardiology. March 2015.

Successful pharmaceutical-grade streptozotocin (STZ)-induced hyperglycemia in a conscious tethered baboon (Papio hamadryas) model. Frost PA, Chen S, Mezzles MJ, Voruganti VS, Nava-Gonzalez EJ, Arriaga-Cazares HE, Freed KA, Comuzzie AG, DeFronzo RA, Kent JW Jr., Grayburn PA, Bastarrachea RA. Journal of Medical Primatology.

August 2015.

Surgical ablation of atrial fibrillation during mitral-valve surgery. Gillinov AM, Gelijns AC, Parides MK, DeRose JJ Jr., Moskowitz AJ, Voisine P, Ailawadi G, Bouchard D, Smith PK, Mack MJ, Acker MA, Mullen JC, Rose EA, Chang HL, Puskas JD, Couderc JP, Gardner TJ, Varghese R, Horvath KA, Bolling SF, Michler RE, Geller NL, Ascheim DD, Miller MA, Bagiella E, Moquete EG, Williams P, Taddei-Peters WC, O’Gara PT, Blackstone EH, Argenziano M; CTSN Investigators. The New England Journal of Medicine. April 2015.

Surgical repair of renal artery aneurysms. Titze N, Ivanokuff V, Fisher T, Pearl G, Grimsley B, Shutze WP. Proc (Baylor University Medical Center). 2015.

The ABLATE Trial: Safety and Efficacy of Cox Maze-IV Using a Bipolar Radiofrequency Ablation System. Philpott JM, Zemlin CW, Cox JL, Stirling M, Mack MJ, Hooker RL, Morris A, Heimansohn DA, Longoria J, Gandhi DB, McCarthy PM. The Annals of Thoracic Surgery.

November 2015.

The future of transcatheter aortic valve implantation. Hamm CW, Arsalan M, Mack MJ. Eur Heart J. November 2015.

The Future of Transcatheter Aortic Valve Interventions: Competitive or Complementary Role of Repair vs.

Replacement? Maisano F, Alfieri O, Banai S, Buchbinder M, Colombo A, Falk V, Feldman T, Franzen O, Herrmann H, Kar S, Kuck KH, Lutter G, Mack MJ, Nickenig G, Piazza N, Reisman M, Ruiz CE, Schofer J, Søndergaard L, Stone GW, Taramasso M, Thomas M, Vahanian A, Webb J, Windecker S, Leon MB. European Heart Journal. April 2015.

The impact of a second arterial graft on 5-year outcomes after coronary artery bypass grafting in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery Trial and Registry. Parasca CA, Head SJ, Mohr FW, Mack MJ, Morice MC, Holmes DR Jr., Feldman TE, Colombo A, Dawkins KD, Serruys PW, Kappetein AP; SYNTAX Investigators. The Journal of Thoracic Cardiovascular Surgery. May 2015.

The Impact of Aneurysm Morphology and Anatomical Characteristics on Long-Term Survival After EVAR. Shutze WP, Cumbie T, Barber M, Mahajan A, Shutze Jr W, Sass D, Filardo G. Annals of Vascular Surgery. July 2015.

The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.

Ramlawi B, Abu Saleh WK, Edgerton J. Methodist DeBakey Cardiovascular Journal.

April 2015.

The MitraClip® and survival in patients with mitral regurgitation at high risk for surgery: A propensity-matched comparison. Velazquez EJ, Samad Z, AlKhalidi HR, Sangli C, Grayburn PA, Massaro JM, Stevens SR, Feldman TE, Krucoff MW. American Heart Journal.

November 2015.

The Therapeutic Effect of Endostar on Soft Carotid Plaque Neovascularization in Patients with Non-Small Cell Lung Cancer. Pu Z, Wang Y, Zhang Y, Huang J, Hong Y, He H, Liu C, Chen S, Grayburn PA, Huang P. Scientific Reports. March 2015.

Transapical and Transaortic Transcatheter Aortic Valve Replacement in the United States. Thourani VH, Jensen HA, Babaliaros V, Suri R, Vemulapalli S, Dai D, Brennan JM, Rumsfeld J, Edwards F, Tuzcu EM, Svensson L, Szeto WY, Herrmann H, Kirtane AJ, Kodali S, Cohen DJ, Lerakis S, Devireddy C, Sarin E, Carroll J, Holmes D, Grover FL, Williams M, Maniar H, Shahian D, Mack MJ. The Annals of Thoracic Surgery.

November 2015.

Transcatheter mitral valve replacement for the treatment of mitral regurgitation: in-hospital outcomes of an apically tethered device. Moat N, Duncan A, Lindsay A, Quarto C, Blanke P, Leipsic J, Grayburn P, Davies S. Journal of the American College of Cardiology. June 2015.

Transcatheter valve therapy registry is a model for medical device innovation and surveillance. Carroll JD, Shuren J, Jensen TS, Hernandez J, Holmes D, Marinac-Dabic D, Edwards FH, Zuckerman BD, Wood LL, Kuntz RE, Mack MJ. Health Affairs.

February 2015.

Tricuspid regurgitation diagnosis and treatment. Arsalan M, Walther T, Smith RL, Grayburn PA. European Heart Journal.

September 2015.

Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation. Goldstein D, Moskowitz AJ, Gelijns AC, Ailawadi G, Parides MK, Perrault LP, Hung JW, Voisine P, Dagenais F, Gillinov AM, Thourani V, Argenziano M, Gammie JS, Mack MJ, Demers P, Atluri P, Rose EA, O’Sullivan K, Williams DL, Bagiella E, Michler RE, Weisel RD, Miller MA, Geller NL, TaddeiPeters WC, Smith PK, Moquete E, Overbey JR, Kron IL, O’Gara PT, Acker MA; CTSN. The New England Journal of Medicine.

May 2015.

Twofers and Transaortic Valve Replacements. Holmes DR Jr., Mack MJ. JACC: Cardiovascular Interventions.

May 2015.

Uncertainty and Possible Subclinical Valve Leaflet Thrombosis. Holmes DR, Mack MJ. The New England Journal of Medicine. November 2015.

Urban Blunt Carotid and Vertebral Artery Injury: A 12 Year Comparison. Lytle M, West J, Burkes J, Fisher T, Doud Y, Shutze WP. Annals of Vascular Surgery. May 2015.

77

PUBLICATIONS Use of novel antiplatelet agents in acute coronary syndromes. Luna M, Holper EM. Current Atherosclerosis Reports. March 2015.

Validation of the SYNTAX revascularization index to quantify reasonable level of incomplete revascularization after percutaneous coronary intervention. Généreux P, Campos CM, Farooq V, Bourantas CV, Mohr FW, Colombo A, Morel MA, Feldman TE, Holmes DR Jr., Mack MJ, Morice MC, Kappetein AP, Palmerini T, Stone GW, Serruys PW. The American Journal of Cardiology.

April 2015.

Value of Interactive Scanning for Improving the Outcome of NewLearners in Transcontinental Tele-Echocardiography (VISION-inTele-Echo) Study. Bansal M, Singh S, Maheshwari P, Adams D, McCulloch ML, Dada T, Sengupta SP, Kasliwal RR, Pellikka PA, Sengupta PP; VISION-in-Tele-Echo Study Investigators. Sengupta PP, Adams D, Kasliwal RR, Bansal M, Soni-Patel N, McClanahan C, Neary J, McCulloch ML, de los Santos L, Roberts B, Canaday B, Shea E, Garcia R, Billick K, GenKuong B, Strachan G, Mesa G, Dittrich T, Belcik T, Dantin L, Ziv Y, Mueller S, Smith Z, Reuter J, Duggal A, Pillai V, Sharma T, Shilpa M, Singh A, Singh R, Insan N, Price R, Van Hoever A, Alsandook M, Asch F, Banchs J, Bhave N, Bodine C, Caselli S, Pietro OS, Cavalcante J, Chen-Tournoux A, Chrissoheris M, Cujec B, Desai M, Dokainish H, Espinosa R, Fornace J, Friedman B, Gardin J, Goldstein S, Gopal A, Grayburn PA, Hamdy AM, Haridas A, Hernandez G, Hixson C, Hristova K, Jiang L, Kane G, Khandheria B, Kirkpatrick J, Klein A, Konety S, Lindner J, Maganti K, Maisuradze D, Mankad S, McCarty D, McNamara R, Meyer T, Naqvi T, Pandian N, Pandya M, 78

Patel A, Patel R, Pellikka PA, Picard M, Prakash S, Puthumana J, Quinones M, Rahko P, Ramrakhiani S, Rovner A, Samad Z, Seward J, Silverman D, Singh G, Sorrell V, Spencer K, Szawaluk J, Thavendiranathan P, Thomas J, Villarraga H, Weiss R. Journal of the American Society of Echocardiography.

January 2015.

Value of interactive scanning for improving the outcome of newlearners in transcontinental teleechocardiography (VISION-in-Tele-Echo) study. Grayburn PA, Bansal M, Singh S, Maheshwari P, Adams D, McCulloch ML, Dada T, Sengupta SP, Kasliwal RR, Pellikka PA, Sengupta PP. Journal of the American Society of Echocardiography. January 2015.

Ventricular assist devices: The future is now. Lima B, Mack MJ, Gonzalez-Stawinski GV. Trends in Cardiovascular Medicine.

May 2015.

Vertebral artery disease. Pearl GJ, Shutze WP. Scientific American Vascular and Endovascular Surgery. May 2015.

Viewpoint: transitions in cardiac surgery and interventional cardiology… teammates or rivals? Verrier ED, Mack MJ. Heart. March 2015.

Why Build an Aortic Center? Arko FR, Gable DR. Endovascular Today. 2015.

DATA SOURCES/APPENDIX The NCDR ® An initiative of the American College of Cardiology Foundation , the National Cardiovascular Data Registry (NCDR) began in 1997 to help healthcare provider groups and institutions respond to increasing requirements to document their processes and outcomes of care in the cath lab setting. Today, the NCDR is the most comprehensive outcomes-based quality improvement program in the United States, encompassing both hospital-based registries and a practice-based program. ®

For hospital-based cardiovascular registries: ACTION Registry® – GWTGTM For acute coronary syndrome patients: CathPCI Registry® For diagnostic cardiac catheterizations and percutaneous coronary interventions:

The Society of Thoracic Surgeons (STS) National Database The Society of Thoracic Surgeons is a not-for-profit organization representing more than 5,800 surgeons, researchers and allied health professionals worldwide who are dedicated to ensuring the best possible heart, lung, esophageal and other surgical procedures for the chest. The Society of Thoracic Surgeons offers outcome programs in the areas of Adult Cardiac, General Thoracic and Congenital surgery. By committing to collecting outcomes data to the STS National Database, surgeons are committing to improving the quality of care that their cardiothoracic surgery patients receive. Since 1994, more than 40 publications have come from the STS National Database. These studies have been published in a variety of professional journals and textbooks. The STS National Database has recently served as the basis for a federally funded national quality improvement randomized trial, as well as research in targeted areas of cardiac surgery.

Pathways Powered by M2S Through VQI The Vascular Quality Initiative (VQI) is a collaborative of regional quality groups collecting and analyzing data in an effort to improve patient care.

ICD RegistryTM For implantable cardioverter defibrillators: TVT RegistryTM For Transcatheter Aortic Valve Replacement

79

HELPFUL TELEPHONE NUMBERS Access Services (Admitting) ............................................ 469-814-4100

Emergency Department ................................................... 469-814-3575

Administration ................................................................. 469-814-3500

Environmental Services ................................................... 469-814-3773

Comprehensive Care Management .................................. 469-814-3399

Health Information Records (Medical Records) ................ 469-814-4360

Cardiopulmonary Rehabilitation ....................................... 469-814-3850

Human Resources ........................................................... 469-814-3540

Cardiac Universal Bed 2nd Floor ..................................... 469-814-4240

Imaging Services ............................................................. 469-814-4350

Cardiac Universal Bed 3rd Floor ..................................... 469-814-3340

Marketing ........................................................................ 469-814-3359

Cardiac Universal Bed 4th Floor ..................................... 469-814-3440

Nutrition Services ............................................................ 469-814-3742

Cardiac Universal Bed 5th Floor ..................................... 469-814-4540

Pastoral Care ................................................................... 469-814-3344

Cardiac Universal Bed 6th Floor ..................................... 469-814-4640

Public Safety ................................................................... 469-814-4444

Catheterization Laboratory .............................................. 469-814-4375

Respiratory Services ....................................................... 469-814-3778

Center for Advanced Cardiovascular Care ....................... 469-814-3480

Stress Lab ....................................................................... 469-814-4332

Central Scheduling ...................................................... 1-866-810-1168

To find a physician: 1-800-4BAYLOR

Concierge (1st Floor) ....................................................... 469-814-3566 Concierge (2nd Floor) ....................................................... 469-814-4263 Concierge (3rd Floor) ....................................................... 469-814-3363

For acute aortic emergencies, please call our Patient Transfer Center for the Thoracic Aortic Referral Program at 214-820-6444.

Concierge (4th Floor) ....................................................... 469-814-3458

For questions about our medical staff, please call 469-814-3516.

Education ........................................................................ 469-814-4772 Electrophysiology Laboratory .......................................... 469-814-4320

80

FOR PHYSICIANS ONLY:

Mike Gonzalez Patient Spotlight

Frisco, TX Former Guest, The Heart Hospital Baylor Plano

Officer Mike Gonzalez, a 12-year police veteran and competitive powerlifter, was in great shape. Then a fierce case of H1N1 flu nearly killed him. By the time he got to The Heart Hospital Baylor Plano, he’d already been given last rites. Here, he was put on extracorporeal membrane oxygenation (ECMO), a machine that takes over for the heart and lungs to oxygenate the blood.

He spent a month on ECMO and underwent weeks of physical therapy. Now he’s back to policing, weight lifting and being grateful.

“I’m more appreciative than I can tell you.”

1100 ALLIED DRIVE, PLANO TEXAS 75093 1.800.4BAYLOR | TheHeartHospitalBaylor.com Physicians provide clinical services as members of the medical staff at one of Baylor Scott & White Health’s subsidiary, community or affiliated medical centers and do not provide clinical services as employees or agents of those medical centers, Baylor Health Care System, Scott & White Healthcare or Baylor Scott & White Health. © 2016 Baylor Scott & White Health THHBP_1021_2016_THHBP_Outcomes_Report_2016

N o H e a r t L i k e Yo u r s . N o C a re L i k e O u r s .™